{"study_id": 81453, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate melatonin's role in addressing sleep disturbances and circadian rhythm disorders, as well as its therapeutic potential in various diseases linked to melatonin dysfunction.", "results_summary": "Melatonin immediate release was effective at moderate doses for improving sleep onset and circadian rhythm-related disorders, while prolonged-release formulations and synthetic agonists were developed for extended therapeutic actions. Melatonin dysfunction was associated with multiple diseases, including dementia, mood disorders, and diabetes.", "population_specificity": "General population, with specific mention of aging individuals and those with diseases like dementia, mood disorders, and diabetes.", "effective_dosage": "Moderate doses (specific amount not stated) for immediate release; prolonged-release and synthetic agonists also mentioned.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:37:54.586322+00:00"}
{"study_id": 81454, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether tryptophan-enriched cereals could improve sleep/wake cycle consolidation and reduce depression and anxiety symptoms in middle-aged/elderly individuals.", "results_summary": "The study found that higher-dose tryptophan-enriched cereals improved sleep efficiency, actual sleep time, and reduced nocturnal activity, while also increasing urinary melatonin and serotonin metabolites and antioxidant capacity, alongside alleviating anxiety and depression symptoms.", "population_specificity": "Middle-aged/elderly volunteers (aged 55-75 years).", "effective_dosage": "60 mg tryptophan in 30 g cereals per dose, consumed at breakfast and dinner.", "study_duration": "1 week (treatment week).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:37:55.853725+00:00"}
{"study_id": 81455, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the relative and combined efficacy of controlled-release melatonin and cognitive-behavioural therapy in treating sleep disorders in children with autism spectrum disorders.", "results_summary": "Melatonin significantly reduced insomnia symptoms, while cognitive-behavioural therapy had a modest impact on sleep latency. The combination treatment showed the best results, with higher treatment response rates and clinically significant improvements in sleep efficiency and latency.", "population_specificity": "Children aged 4-10 years with autism spectrum disorders suffering from sleep onset insomnia and impaired sleep maintenance.", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:37:55.915402+00:00"}
{"study_id": 81456, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review melatonin's proapoptotic effects in cancer cells and its potential clinical implications for cancer prevention and treatment.", "results_summary": "Melatonin was found to inhibit tumor development and growth in various experimental models, promote apoptosis in tumor cells, and exhibit oncostatic properties. Depressed melatonin levels were associated with various tumor types.", "population_specificity": "Experimental preclinical models (in vitro and in vivo) and some human cell lines.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:37:56.355972+00:00"}
{"study_id": 81457, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to review interventions for sleep problems in children with cerebral palsy (CP) or traumatic brain injury (TBI), including melatonin's effects.", "results_summary": "Melatonin improved sleep latency and night waking in CP patients with phase or sleep maintenance disorders, with some showing increased total sleep time. No studies exclusively focused on CP or TBI patients using melatonin.", "population_specificity": "Children aged 0-12 years with CP or TBI, and other medical conditions where sleep was measured.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:37:58.258328+00:00"}
{"study_id": 81459, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review current pharmacotherapy options for insomnia, including melatonin receptor antagonists like ramelteon, and assess their efficacy and potential as treatments.", "results_summary": "The abstract mentions ramelteon as an alternative for patients with sleep-onset difficulty but does not provide specific efficacy data for melatonin itself. It highlights the need for more randomized controlled trials to evaluate short-term and long-term effects of these medications.", "population_specificity": "Patients with insomnia, particularly those with sleep-onset difficulty.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:37:59.413714+00:00"}
{"study_id": 81458, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to examine the effects of melatonin on growth and apoptosis in various human lymphoid malignancy cell lines to assess its potential as a chemotherapeutic or preventive agent.", "results_summary": "Melatonin promoted cell cycle arrest and apoptosis in all tested lymphoid malignancy cell lines, with varying sensitivity levels. It induced rapid apoptosis via caspase activation and mitochondrial dysfunction, though the extrinsic pathway's role was inconsistent.", "population_specificity": "Human lymphoid malignancy cell lines (Ramos, SU-DHL-4, DoHH2, JURKAT).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:37:59.421203+00:00"}
{"study_id": 81460, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the relationship between sleep and circadian rhythm disturbances in Alzheimer's disease (AD) and the potential role of melatonin in AD pathophysiology.", "results_summary": "The abstract suggests that melatonin and other neurotransmitters may influence AD pathology, linking sleep and circadian rhythm deterioration to the onset of AD, but does not provide specific efficacy data.", "population_specificity": "Individuals with Alzheimer's disease (AD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:00.476735+00:00"}
{"study_id": 81461, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the role of melatonin in oxidative stress, autophagy activation, and mitophagy, focusing on its protective effects in health and disease.", "results_summary": "The study highlights melatonin's high efficacy as an antioxidant, its documented protective actions against oxidative stress, and its beneficial effects against mitochondrial dysfunction, suggesting a link to mitophagy.", "population_specificity": "Not specified (review of experimental and clinical data).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:01.619162+00:00"}
{"study_id": 81463, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to explore the potential role of hormonal deficiencies, including melatonin, in skin aging and the effectiveness of replacement therapies.", "results_summary": "The abstract suggests that melatonin replacement therapy for skin aging remains controversial, with no clear efficacy demonstrated. Hormonal influences on skin functions are noted, but specific outcomes for melatonin are not detailed.", "population_specificity": "General aging population (both males and females)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:02.885419+00:00"}
{"study_id": 81462, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore melatonin's role in Plasmodium falciparum growth and differentiation and investigate methods to counteract its effects to eliminate the parasite.", "results_summary": "The study found that melatonin influences Plasmodium growth via interconnected signaling pathways, and its antagonist, luzindole, effectively reduces parasite growth. Suppressing melatonin levels through bright light or anti-melatonergic drugs shows potential for malaria control.", "population_specificity": "Rodents and humans (general malaria-affected populations).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:03.835244+00:00"}
{"study_id": 81464, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review melatonin's role in the etiology, pathophysiology, and treatment of schizophrenia, including its effects on symptoms and antipsychotic side effects.", "results_summary": "Melatonin levels and circadian rhythms are significantly decreased in schizophrenia patients. Adjunctive melatonin may improve antipsychotic efficacy, sleep disorders, and side effects like tardive dyskinesia and metabolic syndrome through anti-inflammatory and antioxidative effects.", "population_specificity": "Schizophrenia patients", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:03.877898+00:00"}
{"study_id": 81465, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the therapeutic usefulness of melatonin in various medical conditions, focusing on its antioxidant, anti-inflammatory, and immune-stimulating properties.", "results_summary": "Clinical trials demonstrated melatonin's effectiveness in preventing cell damage in acute (e.g., sepsis, newborn asphyxia) and chronic conditions (e.g., metabolic diseases, neurodegenerative disorders, cancer, inflammation, aging). Its benefits were attributed to antioxidant properties, apoptosis regulation, and immune function stimulation, supporting its use in viral infections associated with oxidative stress and inflammation.", "population_specificity": "Broad clinical populations, including those with acute and chronic conditions, and viral infections.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:07.282723+00:00"}
{"study_id": 81467, "supplement_id": 1328, "safety_score": "90", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential oncostatic properties of melatonin, particularly its antiestrogenic and antioxidant effects, in breast cancer prevention and treatment of therapy-related side effects.", "results_summary": "The study suggests melatonin has promising antiestrogenic and antioxidant properties, making it a potential adjuvant for breast cancer prevention and for mitigating side effects of chemotherapy and radiotherapy, particularly with anthracyclines.", "population_specificity": "Focused on individuals at risk for or undergoing treatment for breast cancer, especially those with obesity, steroid hormone treatment, or chronodisruption due to light exposure at night.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:07.855451+00:00"}
{"study_id": 81466, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether melatonin could reduce oxidative stress and improve symptoms in patients with moderate to very severe COPD.", "results_summary": "Melatonin administration significantly reduced oxidative stress (measured by 8-isoprostane levels) and improved dyspnea, though it did not significantly affect lung function or exercise capacity. Placebo-treated patients showed an increase in IL-8, while melatonin-treated patients did not.", "population_specificity": "36 patients (30 men, mean age 66.6\u00b17.8 years) with clinically stable moderate to very severe COPD.", "effective_dosage": "3mg melatonin daily.", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:08.067607+00:00"}
{"study_id": 81468, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of melatonin as an index of circadian timing and its potential to address sleep and circadian rhythm disruptions in polar regions.", "results_summary": "The study found that melatonin serves as a reliable marker for circadian timing, with light treatments (including blue-enriched light) effectively advancing circadian phase and improving sleep. Delayed circadian rhythms in winter were common, but timed light interventions helped restore normal sleep patterns.", "population_specificity": "Personnel in Arctic and Antarctic regions, and high-latitude North Sea oil installations.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:08.791571+00:00"}
{"study_id": 81470, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine if the beneficial effects of a 12-week melatonin course on liver enzymes in NASH patients could be sustained with prolonged treatment and after discontinuation.", "results_summary": "Melatonin significantly reduced ALT, AST, and GGT levels in treated patients compared to controls, with sustained effects post-treatment. No significant changes were observed in cholesterol, triglycerides, glucose, or alkaline phosphatase levels in either group.", "population_specificity": "42 patients with histologically proven nonalcoholic steatohepatitis (NASH).", "effective_dosage": "2x5 mg daily.", "study_duration": "12 weeks of treatment followed by 12 weeks of follow-up.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:11.913667+00:00"}
{"study_id": 81469, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the efficacy of melatonin and melatonergic drugs (e.g., ramelteon, agomelatine) in treating insomnia and sleep disturbances associated with depressive disorders.", "results_summary": "Melatonin and its slow-release preparations improve sleep, but ramelteon, a selective MT1/MT2 agonist, showed greater efficacy in improving sleep quality, sleep efficiency, and reducing sleep onset time. Agomelatine, another melatonergic drug, also improved sleep quality and efficiency while acting as an antidepressant.", "population_specificity": "Elderly and adult populations with insomnia or depressive disorders.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:12.077421+00:00"}
{"study_id": 81472, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the geroprotective effects of epithalamin (a peptide drug) on the cardiovascular system, including its impact on melatonin production, in elderly coronary patients.", "results_summary": "Long-term treatment with epithalamin slowed cardiovascular aging, improved physical endurance, normalized melatonin circadian rhythm, and enhanced carbohydrate and lipid metabolism. Mortality was significantly lower in the epithalamin group compared to controls.", "population_specificity": "Elderly coronary patients with rapidly aging cardiovascular systems.", "effective_dosage": "Not specified (6 courses over 3 years).", "study_duration": "3 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:12.731824+00:00"}
{"study_id": 81471, "supplement_id": 1328, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the combined effects of melatonin, vitamin E, and betaglucan (MEB) complexed with chitin nano-crystals on skin hydration, elasticity, peroxidation, and global clinical appearance in aging skin.", "results_summary": "The study found that MEB, especially when complexed with chitin nano-crystals, significantly improved skin hydration, elasticity, and overall appearance compared to placebo, with positive results observed as early as week 4 and no reported side effects.", "population_specificity": "70 healthy subjects affected with skin photo-aging.", "effective_dosage": "Not specified in the abstract.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:13.662837+00:00"}
{"study_id": 81473, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 50, "study_goal": "The researchers aimed to explore the role of reduced melatonin production in circadian sleep disorders following traumatic brain injury.", "results_summary": "The abstract suggests that reduced evening melatonin production due to traumatic brain damage may disrupt circadian regulation of sleep and wakefulness, but direct evidence or outcomes are not detailed.", "population_specificity": "Individuals with traumatic brain injury experiencing sleep-wake disturbances.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:14.417965+00:00"}
{"study_id": 81474, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to review alternative therapies, including melatonin, for Hemicrania Continua (HC) due to the risks associated with standard indomethacin treatment.", "results_summary": "Melatonin was listed as a possible alternative treatment for HC, but no specific efficacy data or outcomes related to melatonin were provided in the abstract.", "population_specificity": "Patients with Hemicrania Continua (HC) treated at a headache outpatient clinic.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:15.894157+00:00"}
{"study_id": 81475, "supplement_id": 1328, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy and safety of prolonged-release melatonin (Circadin\u00ae) for treating insomnia in elderly patients.", "results_summary": "The study found that Circadin improved sleep quality, latency, next-day alertness, and quality of life, with no rebound, withdrawal, or hangover effects. It was well-tolerated and showed no adverse effects on cognition, memory, or postural stability.", "population_specificity": "Patients aged 55 years and older with insomnia.", "effective_dosage": "2 mg once daily.", "study_duration": "3 months.", "interactions": "None mentioned with antihypertensive, antidiabetic, lipid-lowering, or anti-inflammatory drugs.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:16.918750+00:00"}
{"study_id": 81476, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the potential role of melatonin in improving sleep and reducing delirium in ICU patients, given its effects on circadian rhythm and other physiological functions.", "results_summary": "The abstract notes that melatonin's role in ICU patients remains unclear due to limited and methodologically heterogeneous studies, making definitive recommendations impossible at this stage. It highlights the need for well-designed randomized controlled trials to assess melatonin's efficacy in this setting.", "population_specificity": "Critically ill patients in the intensive care unit (ICU).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:17.111156+00:00"}
{"study_id": 81477, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of melatonin within the circadian neuroendocrine-immune network and its implications for disease pathophysiology and management, particularly in chronic inflammatory conditions like rheumatoid arthritis.", "results_summary": "The study highlights melatonin's role in activating the nighttime immune response as part of the circadian neuroendocrine-immune network, suggesting its involvement in regulating immune/inflammatory activity, especially in conditions like rheumatoid arthritis where cortisol production is insufficient.", "population_specificity": "Individuals with chronic immune/inflammatory conditions, such as rheumatoid arthritis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:19.628108+00:00"}
{"study_id": 81479, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the potential neuroprotective effects of melatonin against diclofenac sodium-induced neurotoxicity.", "results_summary": "The study suggests melatonin has neuroprotective properties due to its antioxidant and free-radical scavenging activities, potentially counteracting the adverse cerebral and cerebellar effects of diclofenac sodium. It highlights melatonin's ability to cross the blood-brain barrier and protect against free-radical damage in the CNS.", "population_specificity": "Not specified (general CNS-related conditions).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:20.847645+00:00"}
{"study_id": 81478, "supplement_id": 1328, "safety_score": "75", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to evaluate melatonin's role in protecting mitochondrial function and its potential therapeutic effects in neurodegenerative disorders like Alzheimer's, Parkinson's, and Huntington's disease.", "results_summary": "Melatonin was found to effectively prevent oxidative/nitrosative stress-induced mitochondrial dysfunction in experimental models of neurodegenerative diseases, with clinical studies indicating improvements in sleep and circadian rhythm disruption in PD and AD patients. Higher doses (50-100mg/day) may be needed for therapeutic effects in neurodegenerative disorders.", "population_specificity": "Experimental models of Alzheimer's, Parkinson's, and Huntington's disease, and clinical studies in PD and AD patients.", "effective_dosage": "50-100mg/day (therapeutic range suggested for neurodegenerative disorders).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:21.888109+00:00"}
{"study_id": 81481, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate melatonin's potential in breast cancer therapy, focusing on its SERM and SEEM properties and the impact of light-at-night on melatonin suppression.", "results_summary": "Melatonin demonstrated oncostatic properties by modulating estrogen-regulated cell proliferation and enzyme activity, with effects mediated by MT1 receptors. Light-at-night suppressed melatonin production, increasing breast cancer risk, while filtering blue light was proposed to mitigate this risk.", "population_specificity": "Primarily focused on breast cancer cells expressing ER\u03b1 and rat mammary tumors; epidemiologic studies included women exposed to light-at-night.", "effective_dosage": "Physiologic doses (specific amounts not provided)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:23.791164+00:00"}
{"study_id": 81480, "supplement_id": 1328, "safety_score": "90", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to assess compliance with and the effects of melatonin supplementation on breast cancer biomarkers (estradiol, IGF-1, IGFBP-3, and IGF-1/IGFBP-3 ratio) in postmenopausal breast cancer survivors.", "results_summary": "Melatonin was well tolerated with high compliance (89.5%) but did not significantly influence circulating estradiol, IGF-1, or IGFBP-3 levels after 4 months of supplementation. Low baseline estradiol levels may have limited the ability to detect further estradiol-lowering effects.", "population_specificity": "Postmenopausal women with a prior history of stages 0-III breast cancer who had completed active cancer treatment.", "effective_dosage": "3 mg oral melatonin daily", "study_duration": "4 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:24.312356+00:00"}
{"study_id": 81482, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the role of melatonin as a chronobiotic in normalizing circadian rhythm disruption in shift work disorder (SWD).", "results_summary": "Melatonin was recommended as a therapy for altering the circadian cycle in SWD, alongside other interventions like timed light exposure, but no therapies fully restored circadian cycles to baseline levels.", "population_specificity": "Shift workers with shift work disorder (SWD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:24.668587+00:00"}
{"study_id": 81484, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the melatonergic system's role in depression and assess the antidepressant potential of melatonin receptor agonists like agomelatine.", "results_summary": "The study found that melatonin receptor agonists, particularly agomelatine, effectively treat depressive and anxiety symptoms in major depression, with rapid benefits on sleep regulation. Dysfunctions in the melatonergic system may contribute to depression, suggesting new avenues for antidepressant development.", "population_specificity": "Patients with major depression (specific demographics not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:25.862295+00:00"}
{"study_id": 81483, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to compare the pharmacokinetic properties of low-dose (0.4mg) and high-dose (4.0mg) melatonin in a combined immediate-release/controlled-release formulation in older adults with insomnia and low endogenous melatonin levels.", "results_summary": "The study found no significant differences in pharmacokinetic parameters between low- and high-dose melatonin, but both doses resulted in substantially higher melatonin levels than typical physiologic levels for the age group. High-dose melatonin maintained elevated levels for an average of 10 hours, potentially extending beyond the typical sleep period, while renal and liver function remained stable after 6 weeks of treatment.", "population_specificity": "Older adults with insomnia complaints and low endogenous melatonin levels (n=27).", "effective_dosage": "0.4mg (low-dose) and 4.0mg (high-dose), both as 25% immediate-release and 75% controlled-release formulations.", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:28.848984+00:00"}
{"study_id": 81486, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore melatonin's protective effects against stress-induced gastrointestinal lesions and its role in the brain-gut axis.", "results_summary": "Melatonin demonstrated important protective effects against stress-induced gastrointestinal lesions, suggesting its potential as a mediator in the brain-gut axis. The abstract also highlights probiotics' role in attenuating stress-induced gastrointestinal disorders.", "population_specificity": "Not specified (general discussion on stress-induced gastrointestinal disorders).", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:28.983434+00:00"}
{"study_id": 81485, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of a dietary supplement containing melatonin, DHA-phospholipids, and tryptophan in improving cognitive function and nutritional status in elderly subjects with mild cognitive impairment.", "results_summary": "The study found significant improvements in cognitive function (MMSE) and olfactory sensitivity, along with a positive trend in semantic verbal fluency and nutritional status (MNA score) in the supplemented group compared to placebo.", "population_specificity": "Elderly subjects (86 \u00b1 6 years, 20 females, 5 males) with mild cognitive impairment (MCI).", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:29.727058+00:00"}
{"study_id": 81487, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to summarize melatonin's metabolism, secretion, regulation, receptor mechanisms, and clinical applications in sleep-wake rhythms, immune function, cancer therapy, and neuroprotection.", "results_summary": "The study highlights melatonin's roles in regulating sleep-wake cycles, immune function, cancer therapy, and neuroprotection through antioxidant activities. It also discusses melatonin's combined effects with other drugs.", "population_specificity": "Not specified (review article)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Combined effects with other drugs mentioned, but specifics not detailed.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:30.212673+00:00"}
{"study_id": 81489, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether melatonin is a safe sleep aid for cardiac patients and if it affects nocturnal breathing patterns in individuals with coronary artery disease (CAD).", "results_summary": "Melatonin did not significantly alter the nocturnal breathing pattern in CAD patients, as measured by the estimated apnoea/hypopnoea index (eAHI). Both melatonin and placebo groups showed similar, minimal changes in eAHI values.", "population_specificity": "60 patients with coronary artery disease, aged 48-80 years.", "effective_dosage": "5 mg daily before bedtime.", "study_duration": "30 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:33.405641+00:00"}
{"study_id": 81488, "supplement_id": 1328, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy and safety of melatonin as an adjunct therapy for solid tumor cancer patients undergoing chemotherapy or radiotherapy.", "results_summary": "Melatonin significantly improved tumor remission rates, 1-year survival, and reduced radiochemotherapy-related side effects such as thrombocytopenia, neurotoxicity, and fatigue, with no severe adverse events reported.", "population_specificity": "Solid tumor cancer patients undergoing chemotherapy or radiotherapy.", "effective_dosage": "20 mg orally, once a day.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:33.407115+00:00"}
{"study_id": 81490, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to clarify the neurophysiological mechanisms underlying circadian rhythm sleep disorders (CRSDs) in children with neurodevelopmental disabilities and assess the potential benefits of timed melatonin replacement therapy.", "results_summary": "The study found that CRSDs in children with neurodevelopmental disabilities are often linked to impaired or mistimed melatonin production/secretion, and timed melatonin replacement therapy can be beneficial in such cases. The abstract suggests that understanding photic and non-photic influences on sleep is crucial for characterizing and treating these disorders.", "population_specificity": "Children with neurodevelopmental disabilities and circadian rhythm sleep disorders.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:34.047569+00:00"}
{"study_id": 81491, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to explore melatonin's diverse physiological roles, including its antimicrobial, antioxidant, and immunomodulatory effects, as well as its therapeutic potential in treating infections and sepsis.", "results_summary": "Melatonin demonstrated effectiveness in combating bacterial and viral infections, including chlamydial infections and Mycobacterium tuberculosis, and showed protective actions against sepsis due to its antioxidant and immunomodulatory properties. It also exhibited potential therapeutic benefits for premature infants with severe respiratory distress syndrome and septic shock.", "population_specificity": "Premature infants, critically ill patients, and general discussion of its effects in various organs and infections.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:34.901627+00:00"}
{"study_id": 81492, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate melatonin's role in metabolic syndrome, focusing on its effects on obesity, insulin resistance, and leptin resistance.", "results_summary": "The study suggests melatonin may play a beneficial role in body weight regulation and energy metabolism, potentially reversing harmful effects of obesity and related metabolic disorders. However, its role in human cardiovascular risk factors remains unestablished.", "population_specificity": "Not specified (general focus on metabolic syndrome and related conditions)", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:36.769589+00:00"}
{"study_id": 81493, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to assess the effects of nightly melatonin supplementation on bone health and quality of life in perimenopausal women.", "results_summary": "Melatonin improved physical domain scores in quality of life and reduced menstrual cycling frequency but showed no significant effects on bone density, bone turnover markers, or other quality-of-life domains. It also did not affect sleep quality or duration.", "population_specificity": "Perimenopausal women aged 45-54 (n=18).", "effective_dosage": "3mg nightly (oral).", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:37.177213+00:00"}
{"study_id": 81494, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effect of oral melatonin supplementation on physiological functions (immune, endocrine, and metabolic parameters) during acute high-intensity exercise in young male athletes.", "results_summary": "Melatonin supplementation reduced oxidative stress (lower MDA levels), improved antioxidant activity (higher TAS), and enhanced lipid metabolism (lower triglycerides) compared to placebo. It also increased IgA levels post-exercise, but no significant differences were found for other variables.", "population_specificity": "16 young male football players", "effective_dosage": "6 mg administered 30 min prior to exercise", "study_duration": "Single acute intervention", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:39.424064+00:00"}
{"study_id": 81495, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether melatonin (MT) or its precursor L-tryptophan (TRP) accelerates the healing of H. pylori-infected gastroduodenal ulcers when combined with omeprazole.", "results_summary": "MT and TRP significantly accelerated ulcer healing compared to omeprazole alone, with all ulcers healed in the MT and TRP groups by day 21, versus only partial healing in the placebo group. Plasma MT and leptin levels rose significantly in treated groups, suggesting a role in gastroprotection.", "population_specificity": "42 H. pylori-positive patients (21 gastric ulcers, 21 duodenal ulcers), aged 28-50 years.", "effective_dosage": "MT 5 mg twice daily; TRP 250 mg twice daily.", "study_duration": "21 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:39.840029+00:00"}
{"study_id": 81498, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the neuroprotective effects of melatonin, alone and combined with physical exercise, in a mouse model of Alzheimer's disease.", "results_summary": "Melatonin decreased hyperphosphorylated tau and immunosenescence, protected against cognitive impairment, brain oxidative stress, and mitochondrial DNA loss, and showed additive effects when combined with physical exercise.", "population_specificity": "3xTg-AD male mice aged 6 to 12 months (moderate to advanced Alzheimer's pathology).", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:42.255670+00:00"}
{"study_id": 81496, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to review and evaluate non-clinical and clinical studies on the efficacy of melatonin in inflammatory bowel disease (IBD).", "results_summary": "The majority of studies indicated melatonin has a positive impact on IBD with minimal side effects, primarily through free radical scavenging and anti-inflammatory effects. Further clinical trials are needed to confirm efficacy and assess long-term side effects.", "population_specificity": "Patients with inflammatory bowel disease (IBD) in both clinical and non-clinical studies.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:42.306210+00:00"}
{"study_id": 81499, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore novel functions of melatonin, including its effects on reproductive organs, fetal development, cancer treatment, and potential industrial applications.", "results_summary": "Melatonin demonstrated protective effects on oocytes, potential benefits for fetal circadian organization, and utility in treating pre-eclampsia, intrauterine growth restriction, endometriosis, and pancreatic cancer. It also showed promise in industrial applications.", "population_specificity": "Not specified (broad range of potential applications, from reproductive health to cancer treatment).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:42.928179+00:00"}
{"study_id": 81497, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the neuroprotective potential of melatonin in Parkinson's disease (PD) models, updating previous reviews with newer models and extensive studies.", "results_summary": "Melatonin demonstrated significant potential in ameliorating PD symptoms in various experimental models, showing anti-inflammatory, anti-apoptotic, and anti-oxidant effects, though some incongruous observations were noted.", "population_specificity": "Experimental models (MPTP, 6-OHDA, methamphetamine, rotenone, maneb, and paraquat) of Parkinson's disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:43.073343+00:00"}
{"study_id": 81500, "supplement_id": 1328, "safety_score": "75", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to evaluate melatonin's therapeutic validity in managing metabolic syndrome (MS) by assessing its chronobiotic, cytoprotective, and immunomodulatory properties.", "results_summary": "Melatonin was found to improve sleep-wake rhythm, prevent hyperadiposity in animal models, and exhibit potential benefits for MS. Clinical trials suggest higher doses (50-100 mg/day) may be needed for therapeutic effects in MS, while low doses (2-5 mg/day) are effective for sleep disorders.", "population_specificity": "Patients with insomnia, circadian rhythm sleep disorders, and animal models of obesity.", "effective_dosage": "2-5 mg/day for sleep disorders; 50-100 mg/day proposed for MS.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:45.992728+00:00"}
{"study_id": 81501, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to assess the dose-response, tolerability, safety, and feasibility of collecting actigraphy data for supplemental melatonin in treating sleep onset insomnia in children with autism spectrum disorders (ASD).", "results_summary": "Supplemental melatonin improved sleep latency in most children at 1 or 3 mg dosages, with effects evident in the first week and maintained over several months. It was well tolerated, safe, and showed improvements in sleep, behavior, and parenting stress.", "population_specificity": "Children with autism spectrum disorders (ASD) who were free of psychotropic medications.", "effective_dosage": "1 or 3 mg", "study_duration": "14 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:45.995350+00:00"}
{"study_id": 81502, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the analgesic activity of melatonin during endotracheal intubation in preterm newborns and assess its impact on inflammatory responses.", "results_summary": "Melatonin-treated infants showed significantly lower pain scores (PIPP) during late-phase intubation and mechanical ventilation compared to the control group. Additionally, melatonin reduced pro-inflammatory and anti-inflammatory cytokine levels more effectively than standard sedation and analgesia.", "population_specificity": "Preterm infants undergoing endotracheal intubation.", "effective_dosage": "Not specified", "study_duration": "Evaluated at 12, 24, 48, 72 hours, and 7 days post-intervention.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:48.078723+00:00"}
{"study_id": 81506, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the modulation of pineal melatonin synthesis, its relationship with neurodegenerative disorders involving central inflammatory responses, and suggest potential therapeutic protocols.", "results_summary": "The study highlights melatonin's dual chronobiotic and non-chronobiotic effects, its varying concentrations in different contexts, and its potential therapeutic relevance in neurodegenerative disorders like Alzheimer's disease.", "population_specificity": "Not specified (review article)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:50.019140+00:00"}
{"study_id": 81505, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to review melatonin's role in immunoenhancement and its potential as an adjuvant therapy for various cancers.", "results_summary": "Melatonin enhances T-helper cell response by releasing cytokines and suppresses neoplastic growth in multiple cancers, including melanoma, breast, prostate, ovarian, and colorectal cancers. It also exhibits antioxidant and immunoenhancing properties.", "population_specificity": "Not specified (broad review of melatonin's effects across species and human applications).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:50.159396+00:00"}
{"study_id": 81503, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether melatonin, alone or in combination with other treatments, improves graft survival and reduces follicular loss in ovarian tissue transplantation.", "results_summary": "Host treatment with melatonin and graft incubation with HA-rich biological glue, especially when combined with VEGF-A and vitamin E, significantly improved graft survival, reduced apoptosis, and minimized follicular loss compared to untreated grafts.", "population_specificity": "Young cancer patients undergoing ovarian tissue cryopreservation for fertility preservation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:50.712797+00:00"}
{"study_id": 81504, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate melatonin's potential to counteract hyperglycemia-induced cellular toxicity, oxidative stress, and inflammation, and its role in improving insulin resistance and metabolic regulation in type 2 diabetes.", "results_summary": "Melatonin demonstrated antioxidative, anti-inflammatory, and epigenetic regulatory properties, effectively scavenging reactive species and blocking pro-inflammatory pathways. It also restored glucose transporter-4 loss in adipocytes and improved insulin resistance, suggesting benefits for metabolic regulation in type 2 diabetes.", "population_specificity": "Patients with type 2 diabetes or metabolic deterioration linked to hyperglycemia and insulin resistance.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:50.791897+00:00"}
{"study_id": 81507, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate melatonin's effectiveness in improving sleep quality and cognitive performance in individuals with mild cognitive impairment (MCI) and its potential as a therapeutic tool in early Alzheimer's disease.", "results_summary": "The study found that daily evening melatonin improved sleep quality and cognitive performance in MCI patients, with consistent results across five double-blind, randomized placebo-controlled trials and one open-label retrospective study.", "population_specificity": "Individuals with mild cognitive impairment (MCI) and early Alzheimer's disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:51.359267+00:00"}
{"study_id": 81508, "supplement_id": 1328, "safety_score": "80", "efficacy_score": null, "quality_score": 30, "study_goal": "The researchers aimed to assess the effectiveness of melatonin therapy for treating non-respiratory sleep disorders in visually impaired children, focusing on sleep habit, scheduling, and maintenance compared to placebo or no treatment.", "results_summary": "No studies met the inclusion criteria, so no outcome data were reported. Nine studies were excluded due to non-randomization, mixed populations, or age criteria, with no significant adverse effects noted in the excluded studies.", "population_specificity": "Visually impaired children aged 2 to 18 years.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:54.131145+00:00"}
{"study_id": 81509, "supplement_id": 1328, "safety_score": "60", "efficacy_score": 50, "quality_score": 40, "study_goal": "The researchers aimed to evaluate the potential antiepileptic effects and safety of melatonin, among other herbs and supplements, in the treatment of epilepsy.", "results_summary": "The abstract suggests melatonin has a rationale for antiepileptic action but may also have proconvulsant effects and potentially serious adverse effects. Herb-drug interactions, particularly involving the P450 hepatic enzyme system and P-glycoprotein transport system, are noted.", "population_specificity": "Patients with epilepsy using alternative medicine products.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Potential pharmacokinetic interactions with the P450 hepatic enzyme system and P-glycoprotein transport system.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:54.796758+00:00"}
{"study_id": 81510, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of melatonin for the treatment of insomnia in Parkinson's disease patients.", "results_summary": "The study found insufficient evidence to conclude efficacy for melatonin (3-5 mg and 50 mg) in treating insomnia in Parkinson's disease patients. No significant adverse effects were reported, but safety was not explicitly assessed.", "population_specificity": "Parkinson's disease patients with non-motor symptoms, specifically insomnia.", "effective_dosage": "3-5 mg and 50 mg (frequency not specified).", "study_duration": "Not specified (studies did not exceed 6 months).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:56.688711+00:00"}
{"study_id": 81514, "supplement_id": 1328, "safety_score": "80", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the safety and efficacy of biologically based CAM, including melatonin, for children and youth with ASD.", "results_summary": "The study found that melatonin is well tolerated, but its efficacy is still being evaluated. Other CAM treatments showed safety concerns without demonstrated efficacy.", "population_specificity": "Children and youth with autism spectrum disorder (ASD)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:57.974800+00:00"}
{"study_id": 81513, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 85, "study_goal": "The researchers aimed to determine whether low to moderate alcohol consumption affects 24-hour urinary melatonin levels in postmenopausal women.", "results_summary": "The study found no significant change in 24-hour urinary melatonin levels after alcohol consumption, suggesting that low to moderate alcohol intake does not affect melatonin levels in this population.", "population_specificity": "Healthy postmenopausal women (n = 51)", "effective_dosage": "Not applicable (study focused on alcohol intake, not melatonin dosage)", "study_duration": "Three 8-week periods", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:58.245348+00:00"}
{"study_id": 81512, "supplement_id": 1328, "safety_score": "80", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to systematically review the effects of Melatonin (MLT) in conjunction with cancer treatments (chemotherapy, radiotherapy, supportive care, and palliative care) on survival rates, tumor response, and chemotherapy-associated toxicities.", "results_summary": "The study found that MLT significantly reduced 1-year mortality (RR = 0.63) and improved tumor response outcomes (complete, partial, and stable disease). MLT also reduced chemotherapy-associated toxicities such as asthenia, leucopenia, nausea and vomiting, hypotension, and thrombocytopenia.", "population_specificity": "Patients with solid tumors receiving chemotherapy, radiotherapy, supportive therapy, or palliative therapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:59.470510+00:00"}
{"study_id": 81515, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the antidepressant effects of agomelatine, focusing on its ability to resynchronize circadian rhythms and its impact on cellular processes related to depression.", "results_summary": "Agomelatine increased brain-derived neurotrophic factor and activity-regulated cytoskeleton associated protein expression, enhanced hippocampal neurogenesis, and attenuated stress-induced glutamate release. These effects were attributed to its dual action on MT\u2081/MT\u2082 and 5-HT2C receptors.", "population_specificity": "Not specified (animal studies and review of experimental studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:38:59.659077+00:00"}
{"study_id": 81517, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to review the role of melatonin abnormalities in sleep dysfunction among children with autism spectrum disorders (ASDs) and its potential as a treatment target.", "results_summary": "The study suggests that melatonin abnormalities may contribute to sleep dysfunction in children with ASDs, highlighting its potential as a treatment target for improving sleep onset and nighttime awakenings.", "population_specificity": "Children with autism spectrum disorders (ASDs) experiencing sleep dysfunction.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:02.394047+00:00"}
{"study_id": 81516, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine whether melatonin could facilitate benzodiazepine withdrawal in schizophrenia patients and assess its impact on sleep, psychophysiology, cognition, social function, and quality of life.", "results_summary": "The abstract does not provide results, as the study appears to be ongoing or not yet concluded.", "population_specificity": "Outpatients aged 18-55 diagnosed with schizophrenia or schizoaffective disorder, treated with antipsychotics and benzodiazepines for at least three months.", "effective_dosage": "Prolonged-release melatonin (Circadin\u00ae) 2 mg daily.", "study_duration": "6 months follow-up, with data collected at 2, 4, and 6 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:02.997931+00:00"}
{"study_id": 81518, "supplement_id": 1328, "safety_score": "90", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether exogenous melatonin, specifically fast-release versus controlled-release formulations, effectively reduces nocturnal blood pressure in patients with nocturnal hypertension.", "results_summary": "The meta-analysis found that controlled-release melatonin significantly reduced both systolic and diastolic nocturnal blood pressure, while fast-release melatonin had no effect. No safety concerns were reported.", "population_specificity": "Patients with nocturnal hypertension (221 participants across seven trials).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:04.143856+00:00"}
{"study_id": 81519, "supplement_id": 1328, "safety_score": "70", "efficacy_score": 60, "quality_score": 50, "study_goal": "The researchers aimed to evaluate the therapeutic value of melatonin for insomnia and compare it with melatonin analogs, focusing on safety, efficacy, and dosage considerations.", "results_summary": "Melatonin was found to improve sleep in insomnia patients without causing hangover or addiction, but its therapeutic value was inconsistent due to short half-life and low doses. Melatonin analogs like ramelteon and agomelatine showed efficacy in improving sleep and treating depression, but long-term safety data are lacking.", "population_specificity": "Insomnia patients and depressed patients.", "effective_dosage": "2-3 mg/day for melatonin; 50-100 mg/day suggested for future studies.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:06.954616+00:00"}
{"study_id": 81520, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 40, "quality_score": 65, "study_goal": "The researchers aimed to determine the effectiveness of Melatonin (20 mg/day) in treating Tardive Dyskinesia (TD) compared to placebo over 12 weeks.", "results_summary": "Two out of seven Melatonin-treated patients showed significant improvement (over 60% reduction in AIMS scores), while the remaining five and all placebo-treated patients showed no difference. No significant overall difference was found between Melatonin and placebo groups.", "population_specificity": "Patients with Tardive Dyskinesia (7 treated with Melatonin, 6 with placebo).", "effective_dosage": "20 mg/day", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:07.172233+00:00"}
{"study_id": 81521, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of exogenous melatonin on wet night frequency, sleep-wake cycle, and melatonin profiles in children with therapy-resistant MNE.", "results_summary": "The study found that exogenous melatonin altered melatonin profiles but did not affect enuresis frequency or sleep-wake cycles in the studied patients. No significant differences were observed between the melatonin and placebo groups.", "population_specificity": "Children with therapy-resistant monosymptomatic nocturnal enuresis (MNE).", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:07.223730+00:00"}
{"study_id": 81511, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review the functional importance of melatonin in the gut, focusing on its effects on GI motility, inflammation, and pain, and evaluate its potential for future treatment of lower gut symptoms or diseases.", "results_summary": "Melatonin is involved in regulating GI functions through specific receptors (MT1, MT2, MT3), with potential benefits for conditions like irritable bowel syndrome, inflammatory bowel disease, and colorectal cancer, though human studies report mixed effects (both beneficial and harmful).", "population_specificity": "Patients with lower GI diseases, including irritable bowel syndrome, inflammatory bowel disease, and colorectal cancer.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:07.494924+00:00"}
{"study_id": 81522, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of ramelteon 8mg on subjective sleep parameters in adults with chronic insomnia using a post-sleep questionnaire-interactive voice response system (PSQ-IVRS).", "results_summary": "Ramelteon 8mg showed a reduction in mean sleep latency compared to placebo at weeks 1, 2, and 3, but none reached statistical significance. No significant differences were found in other sleep parameters, and adverse effects were minimal (headache and somnolence).", "population_specificity": "Adults aged 18-64 years with chronic insomnia.", "effective_dosage": "8mg nightly", "study_duration": "3 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:07.959348+00:00"}
{"study_id": 81523, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 56, "quality_score": 78, "study_goal": "The researchers sought to determine the effect of walnuts, which contain melatonin among other compounds, on cognitive functions like reasoning, memory, and mood in college students.", "results_summary": "Walnuts did not significantly improve mood, non-verbal reasoning, or memory but showed an 11.2% increase in inferential verbal reasoning with a medium effect size.", "population_specificity": "Healthy, young college students.", "effective_dosage": "Not specified (whole walnuts used, not isolated melatonin).", "study_duration": "8 weeks per intervention phase, with a 6-week washout.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:10.294333+00:00"}
{"study_id": 81524, "supplement_id": 1328, "safety_score": "70", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the safety, efficacy, and clinical utility of agomelatine (a melatonin agonist and serotonin antagonist) for treating major depression, focusing on its effects on circadian sleep disturbances and liver safety.", "results_summary": "Agomelatine improved sleep onset and quality, showing superiority to placebo and equivalence to existing antidepressants, but elevated transaminases were observed in 0-4.5% of patients, depending on dosage.", "population_specificity": "Adults with major depression.", "effective_dosage": "25 mg and 50 mg.", "study_duration": "Short-term clinical trials and one relapse prevention trial (exact duration not specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:12.149232+00:00"}
{"study_id": 81525, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to examine the role of abnormal circadian rhythms, including melatonin dysregulation, in psychiatric disorders and assess interventions that correct circadian misalignment.", "results_summary": "The study found that psychiatric conditions like seasonal affective disorder, bipolar disorder, and ADHD are associated with phase delays or advances in melatonin rhythms, suggesting circadian desynchrony. Interventions targeting circadian misalignment showed efficacy in symptom relief.", "population_specificity": "Individuals with seasonal affective disorder, bipolar disorder, and attention deficit/hyperactivity disorder.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:12.713941+00:00"}
{"study_id": 81528, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore Melatonin's role in enhancing angiogenesis through the upregulation of gastrin and matrix metalloproteinase expression in gastroduodenal mucosal defense.", "results_summary": "Melatonin was found to enhance angiogenesis by increasing plasma levels of gastrin and matrix metalloproteinase expression, contributing to mucosal healing. The abstract does not provide detailed quantitative results or statistical significance.", "population_specificity": "Not specified (general gastroduodenal mucosal defense mechanisms).", "effective_dosage": "Not provided", "study_duration": "Not provided", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:14.878877+00:00"}
{"study_id": 81526, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to explore melatonin's roles in the circadian system, including its effects on synchronization of peripheral oscillators and potential clinical applications for circadian, psychiatric, and sleep disorders.", "results_summary": "Melatonin distributes temporal cues from the SCN to target tissues, drives daily rhythmicity in some structures, and synchronizes peripheral oscillators. Exogenous melatonin can synchronize the SCN clock, and melatonin agonists show promise for treating circadian and sleep disorders.", "population_specificity": "Not specified (general discussion of mammalian systems, including humans).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:15.058386+00:00"}
{"study_id": 81527, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the clinical benefits of melatonin and other therapies for treating shift work disorder (SWD).", "results_summary": "The study suggests that melatonin, along with other treatments like caffeine, modafinil, and armodafinil, may improve wakefulness and sleep quality in SWD patients. However, the abstract does not provide specific data on melatonin's efficacy compared to other treatments.", "population_specificity": "Shift workers, particularly those with shift work disorder (SWD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:15.323941+00:00"}
{"study_id": 81530, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the efficacy of oral melatonin for chronic tinnitus and identify patient subsets that benefit most from melatonin therapy.", "results_summary": "Melatonin significantly reduced tinnitus intensity and improved sleep quality compared to placebo, particularly in men, those without depression, untreated patients, and those with severe, bilateral tinnitus or noise exposure history.", "population_specificity": "Adults with chronic tinnitus in a tertiary referral otology and neurotology practice.", "effective_dosage": "3 mg nightly", "study_duration": "30 days per treatment arm, with a 1-month washout period", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:15.996881+00:00"}
{"study_id": 81529, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether adjuvant melatonin therapy could help sustain remission in patients with ulcerative colitis by reducing inflammation and controlling disease activity.", "results_summary": "Melatonin adjuvant therapy helped maintain remission in UC patients over 12 months, with lower disease activity scores and stable CRP levels compared to placebo. Hemoglobin levels remained stable in the melatonin group but declined in the placebo group, and anxiety/depression scores improved, though not significantly between groups.", "population_specificity": "60 patients with left-sided ulcerative colitis (38 women, 22 men, aged 26-49 years) in clinical remission for the past 12 months.", "effective_dosage": "5 mg melatonin daily at bedtime.", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:16.444781+00:00"}
{"study_id": 81531, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "To examine how daytime light exposure affects circadian phase delays and advances in response to timed bright evening or morning light in older adults with insomnia.", "results_summary": "Less daytime light exposure was associated with larger phase delays in response to evening light and delayed wake times, but no such relationship was found for phase advances in response to morning light. Greater daytime light exposure reduced the effectiveness of evening light in shifting circadian phase.", "population_specificity": "Older adults (mean age 63.0 \u00b1 6.43 years) with primary insomnia.", "effective_dosage": "Not specified (study focused on light exposure, not melatonin dosage).", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:18.785012+00:00"}
{"study_id": 81533, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of newer preventive drugs, including melatonin, for migraine treatment.", "results_summary": "The study found that melatonin, along with vitamin E and botulinum toxins, had no or marginal effect in preventing migraines.", "population_specificity": "Not specified (general migraine patients, inferred from context)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:19.732119+00:00"}
{"study_id": 81532, "supplement_id": 1328, "safety_score": "65", "efficacy_score": 50, "quality_score": 80, "study_goal": "The researchers aimed to critically review and evaluate the benefits and risks of agomelatine, a synthetic melatonin analogue, for treating major depression.", "results_summary": "Agomelatine showed modest, statistically significant benefits over placebo in some short-term trials but was not consistently effective across all studies. It was generally well-tolerated but had specific contraindications and required liver function monitoring due to potential liver enzyme elevation.", "population_specificity": "Adults with major depression, including elderly patients in one study.", "effective_dosage": "25 mg and 50 mg doses were studied, with mixed efficacy results.", "study_duration": "Short-term trials and longer-term relapse prevention studies (specific durations not detailed in abstract).", "interactions": "Contraindicated with drugs that potently inhibit cytochrome P450 1A2 enzymes.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:21.372164+00:00"}
{"study_id": 81534, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of melatonin on oocyte quality in women undergoing IVF cycles.", "results_summary": "Melatonin significantly improved the percentage of mature oocytes and the number of high-quality embryos, though fertilization rates and clinical pregnancy rates did not show statistically significant differences.", "population_specificity": "Women undergoing IVF cycles (85 participants, aged not specified).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:21.771474+00:00"}
{"study_id": 81535, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to evaluate differences in the GH-IGF1 axis function, including melatonin levels, between healthy subjects and patients with non-small-cell lung cancer.", "results_summary": "Melatonin showed a clear circadian rhythm in both healthy subjects and cancer patients, but its midline estimating statistic of rhythm (MESOR) did not differ significantly between groups. No significant trend in melatonin levels was observed across cancer stages.", "population_specificity": "11 healthy male subjects (mean age 43.6) and 9 male patients with non-small-cell lung cancer (mean age 51.0).", "effective_dosage": "Not specified", "study_duration": "Blood samples were collected every 4 hours for 24 hours.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:23.568064+00:00"}
{"study_id": 81536, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to investigate whether melatonin (3 mg) could prevent delirium in older postoperative hip fracture patients compared to placebo.", "results_summary": "The abstract describes the study design but does not report results, as the trial is still in progress. The primary outcome is delirium occurrence, with secondary outcomes including severity, duration, and long-term cognitive and functional status.", "population_specificity": "Acutely hospitalized patients aged 65+ admitted for surgical hip fracture repair (n=452).", "effective_dosage": "3 mg melatonin orally at 21:00 h for five consecutive days.", "study_duration": "Five days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:23.944120+00:00"}
{"study_id": 81537, "supplement_id": 1328, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the long-term effectiveness and safety of prolonged-release melatonin (Circadin) in children and adolescents with neurodevelopmental disorders.", "results_summary": "The study found that prolonged-release melatonin significantly improved sleep latency (44% decrease), sleep duration (10.1% increase), reduced awakenings (75% decrease), and enhanced sleep quality (75% improvement) compared to baseline. No serious adverse events or treatment-related comorbidities were reported.", "population_specificity": "88 children (42 girls, 46 boys) with neurodevelopmental disorders.", "effective_dosage": "4-6 mg", "study_duration": "6-72 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:24.411373+00:00"}
{"study_id": 81538, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to explore the role of circadian rhythm abnormalities, particularly melatonin levels, in the pathophysiology and symptoms of fibromyalgia syndrome (FMS).", "results_summary": "The study found that FMS patients exhibit lower melatonin secretion during nighttime, which may contribute to impaired sleep, daytime fatigue, and altered pain perception. It also noted blunted cortisol rhythms and disturbed cytokine levels in FMS patients, suggesting circadian dysregulation as a key factor in the disorder.", "population_specificity": "Patients with fibromyalgia syndrome (FMS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:24.795728+00:00"}
{"study_id": 81540, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to investigate the role of melatonin in regulating circadian rhythms in the gastrointestinal tract (GIT) and its potential therapeutic effects on gastrointestinal diseases.", "results_summary": "The study found that melatonin improves symptoms in patients with IBS and GERD, protects gastrointestinal mucosa, and has strong protective effects on the liver in patients with NASH. It also plays a key role in the internal biological clock related to food intake and myoelectric rhythm.", "population_specificity": "Patients with gastrointestinal diseases (IBS, GERD, NASH) and general discussion of circadian rhythm regulation in humans.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:28.295052+00:00"}
{"study_id": 81539, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate melatonin's role in reducing inner ear damage caused by aminoglycosides and cisplatin, focusing on cochlear and vestibular function.", "results_summary": "Melatonin was up to 150 times more effective than other antioxidants in limiting cochlear side effects of gentamicin, tobramycin, and cisplatin, reduced vestibular hair cell loss in newborn rats, and alleviated subjective tinnitus in patients.", "population_specificity": "Animals (rats) and human patients with tinnitus.", "effective_dosage": "3 mg daily (human study).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:28.426426+00:00"}
{"study_id": 81541, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the potential of melatonin, among other antioxidant therapies, for treating tardive dyskinesia (TD) when used alongside other drug therapies.", "results_summary": "The abstract suggests melatonin could conceivably be used with other drug therapies for TD, but no specific efficacy data or controlled trial results are provided. Its potential benefit is mentioned alongside other antioxidants like vitamin E and B\u2086.", "population_specificity": "Patients with tardive dyskinesia (TD) from long-term use of dopamine receptor-blocking drugs.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:29.536451+00:00"}
{"study_id": 81542, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to explore unconventional treatments for GERD, including melatonin, to address the limitations of current standard therapies.", "results_summary": "The abstract does not provide specific findings about melatonin's effects, only mentioning it as one of several unconventional treatments investigated.", "population_specificity": "GERD patients, particularly those with non-erosive disease.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:29.634678+00:00"}
{"study_id": 81543, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the evidence regarding melatonin's analgesic properties in animals and humans with chronic pain.", "results_summary": "Melatonin demonstrated potent analgesic effects in experimental studies and showed clinical benefits in patients with chronic pain conditions like fibromyalgia, irritable bowel syndrome, and migraine. The mechanism may involve melatonin receptors, opioid \u03bc-receptors, or GABA-B receptors, with potential secondary benefits from improved sleep and reduced anxiety.", "population_specificity": "Animals and humans with chronic pain (fibromyalgia, irritable bowel syndrome, migraine).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:32.707085+00:00"}
{"study_id": 81544, "supplement_id": 1328, "safety_score": "80", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the antidepressant and chronobiotic effects of agomelatine, a melatonin-receptor agonist, compared to other antidepressants.", "results_summary": "Agomelatine showed similar short-term antidepressant efficacy to venlafaxine, fluoxetine, and sertraline, with fewer long-term relapses (23.9% vs. 50.0% placebo). It improved sleep quality and reduced waking after sleep onset, with fewer gastrointestinal, sexual, or metabolic side-effects compared to other antidepressants.", "population_specificity": "Patients with major depression.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:32.923511+00:00"}
{"study_id": 81545, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to explore the potential of melatonin as an antioxidant to reduce cardiovascular toxicity associated with platinum-based chemotherapy in elderly cancer patients.", "results_summary": "The abstract suggests melatonin may help suppress oxidant injury caused by platinum-based compounds, potentially mitigating cardiovascular risks, but specific results on melatonin's efficacy are not detailed.", "population_specificity": "Elderly cancer patients receiving platinum-based chemotherapy.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:33.374854+00:00"}
{"study_id": 81546, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether melatonin protects luteinized granulosa cells from oxidative stress and enhances progesterone production during ovulation.", "results_summary": "Melatonin concentrations in follicular fluid were positively correlated with progesterone levels and negatively correlated with oxidative stress markers. Melatonin treatment reversed the inhibitory effect of H\u2082O\u2082 on progesterone production and improved serum progesterone levels in women with luteal phase defects.", "population_specificity": "Women undergoing in vitro fertilization and embryo transfer (IVF-ET), including a subgroup with luteal phase defects.", "effective_dosage": "3 mg/day at 22:00 hr (clinical trial); 1, 10, 100 \u03bcg/mL (in vitro).", "study_duration": "Throughout the luteal phase (clinical trial); duration of in vitro incubation not specified.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:35.729374+00:00"}
{"study_id": 81548, "supplement_id": 1328, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the role of melatonin in reducing oxidative stress-related complications during pregnancy and the neonatal period, as well as its safety and efficacy.", "results_summary": "Melatonin was found to be highly effective in reducing complications during pregnancy and the neonatal period, with no significant toxicity or side effects reported even with long-term use. It acts as a potent antioxidant and cytoprotective agent, suggesting benefits for neonatal pathologies like asphyxia and sepsis.", "population_specificity": "Pregnant women and newborns, particularly those at risk for oxidative stress-related complications.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:36.750581+00:00"}
{"study_id": 81547, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore methods to enhance antidepressant efficacy, including novel targets like the melatonergic system, and evaluate agomelatine as an example of a melatonin receptor-targeting antidepressant.", "results_summary": "The study highlights that targeting melatonin receptors (e.g., via agomelatine) is an effective antidepressant strategy, with emerging evidence supporting melatonergic systems as unique targets for treatment. Other novel pharmacological treatments are still in development.", "population_specificity": "Not specified (general discussion on antidepressant strategies).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:37.262493+00:00"}
{"study_id": 81549, "supplement_id": 1328, "safety_score": "80", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to review the therapeutic efficacy and medicinal chemistry strategies of melatonin receptor agonists for sleep and circadian-rhythm related disorders.", "results_summary": "The study found that melatonin receptor agonists like ramelteon, prolonged-release melatonin, and tasimelteon have sleep-promoting effects, offering treatment options for insomnia and transient insomnia. Agomelatine was noted as an effective alternative for depression with a favorable side effect profile, while MT\u2082-selective agonists showed potential in reducing NREM sleep onset latency in rats.", "population_specificity": "Humans and rats (for MT\u2082-selective agonist IIK7).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:38.297016+00:00"}
{"study_id": 81550, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the impact of luminous CRT computer monitors on melatonin suppression, comparing it to controlled blue-light and dark conditions.", "results_summary": "Melatonin concentrations significantly decreased under blue-light goggle exposure compared to dark control and monitor-only conditions. The monitor-only condition showed a slight, non-significant reduction in melatonin relative to the dark control.", "population_specificity": "21 participants (specific demographics not detailed).", "effective_dosage": "Not specified (light exposure conditions described).", "study_duration": "Single-night intervention with samples collected at 23:00, midnight, and 01:00.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:39.914526+00:00"}
{"study_id": 81551, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the potential of tasimelteon, a melatonin receptor agonist, for treating insomnia and mood disorders, including its pharmacological and clinical data.", "results_summary": "The abstract notes that clinical trials of tasimelteon have been promising but highlights the need for more extensive testing, including long-term effectiveness and safety, as well as detailed pharmacokinetic and pharmacodynamic reporting.", "population_specificity": "US adult population with insomnia symptoms or chronic insomnia, including those with comorbid depression, anxiety, and pain.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:40.500277+00:00"}
{"study_id": 81552, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to explore the role of melatonin in mitigating migraine symptoms by addressing zinc deficiency and its impact on melatonin synthesis.", "results_summary": "The study suggests that zinc deficiency exacerbates migraine by reducing melatonin synthesis, and supplementation with zinc sulfate, along with vitamins, nearly cured migraine symptoms in participants. Melatonin's antioxidant properties were highlighted as beneficial for migraine relief.", "population_specificity": "30 migraineurs (specific gender distribution not detailed in the abstract).", "effective_dosage": "75 mg of zinc sulfate orally daily, plus one capsule of vitamin B-complex and one capsule of vitamin A or E (first 10 days).", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:41.868575+00:00"}
{"study_id": 81553, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to explore the potential of melatonin as a neuroprotective agent in animal models of perinatal brain injury.", "results_summary": "The abstract mentions melatonin as one of the neuroprotective agents trialed in animal models, suggesting it is being considered for efficacy in protecting the developing brain from injury, though specific results for melatonin are not detailed.", "population_specificity": "Animal models (not specified, but likely includes baboons and other species)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:41.919327+00:00"}
{"study_id": 81554, "supplement_id": 1328, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate melatonin-related findings in autism spectrum disorders (ASD), including its effects on sleep parameters and daytime behavior.", "results_summary": "Melatonin administration in ASD improved sleep duration, sleep onset latency, and daytime behavior with minimal side effects. Abnormal melatonin levels and circadian rhythms were reported in individuals with ASD, and genetic abnormalities affecting melatonin production or receptor function were identified in some cases.", "population_specificity": "Children with autism spectrum disorders (ASD), including autistic disorder, Asperger syndrome, Rett syndrome, and pervasive developmental disorders not otherwise specified.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:44.247059+00:00"}
{"study_id": 81556, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the role of melatonin in stabilizing the sleep-wake circadian rhythm and reducing sleep latency in patients with dementia and Parkinson's disease.", "results_summary": "Melatonin was found to stabilize the sleep-wake circadian rhythm and shorten sleep latency in patients with dementia and Parkinson's disease, suggesting potential benefits for insomnia management in these populations.", "population_specificity": "Patients with dementia and Parkinson's disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:44.706110+00:00"}
{"study_id": 81555, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "To determine if melatonin could reduce oxidative stress in the blood of patients with Duchenne's muscular dystrophy.", "results_summary": "Melatonin treatment normalized oxidative stress markers within 3 months, maintained through 9 months, and was associated with reduced inflammation and muscle injury.", "population_specificity": "10 patients with Duchenne's muscular dystrophy (aged 12.8\u00b10.9 years) and healthy controls.", "effective_dosage": "60mg at 21:00h plus 10mg at 09:00h.", "study_duration": "9 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:44.780271+00:00"}
{"study_id": 81557, "supplement_id": 1328, "safety_score": "90", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the safety and effects of a preoperative single dose of melatonin in patients undergoing major liver resection.", "results_summary": "Melatonin was effectively absorbed with significantly higher serum concentrations compared to controls, showed lower postoperative transaminases, and had no serious adverse events. There was a trend toward shorter ICU and hospital stays in the melatonin group.", "population_specificity": "Patients scheduled for major liver resection (\u22653 segments).", "effective_dosage": "50 mg/kg BW, single dose.", "study_duration": "Single preoperative dose.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:47.034306+00:00"}
{"study_id": 81558, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 50, "study_goal": "The researchers aimed to evaluate the potential of melatonin as a hypnotic for treating insomnia, particularly its role in sleep initiation.", "results_summary": "The abstract states that little data supports melatonin's use for insomnia, but ramelteon, a melatonin agonist, may help with sleep initiation difficulties. Melatonin's efficacy appears limited compared to other treatments discussed.", "population_specificity": "Not specified (general insomnia patients implied).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:47.095034+00:00"}
{"study_id": 81559, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the functions of melatonin in the oral cavity, focusing on its receptors and potential therapeutic benefits for oral diseases.", "results_summary": "Melatonin may suppress oral diseases, showing beneficial effects in periodontal disease, herpes, and oral cancer by protecting oral tissues through receptor-mediated actions and free radical scavenging.", "population_specificity": "Not specified (general review of literature)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:47.374964+00:00"}
{"study_id": 81561, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to explore the hypothesis that melatonin levels decline with aging and that melatonin replacement therapy could mimic the life-extending effects of caloric restriction.", "results_summary": "The study suggests that melatonin acts as a strong antioxidant and its reduction with age may contribute to aging. Fasting increases gastrointestinal melatonin production, and daily melatonin intake might replicate this effect, potentially protecting against age-related diseases like Parkinson's and Alzheimer's.", "population_specificity": "General human population, with implications for aging individuals.", "effective_dosage": "Not specified (daily intake before bedtime mentioned).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:50.314387+00:00"}
{"study_id": 81564, "supplement_id": 1328, "safety_score": "80", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to systematically review the efficacy and safety of exogenous melatonin for treating disordered sleep in individuals with autism spectrum disorders (ASD).", "results_summary": "The literature suggests melatonin has a beneficial effect on sleep in individuals with ASD, with few and minor side effects, but the conclusions are limited by the small number of studies and methodological weaknesses.", "population_specificity": "Individuals with autism spectrum disorders (ASD) experiencing disordered sleep.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:51.751854+00:00"}
{"study_id": 81560, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness and safety of melatonin and its synthetic analogs (ramelteon and agomelatine) for treating insomnia and depression-associated insomnia compared to traditional sedative-hypnotics.", "results_summary": "Melatonin and its analogs (ramelteon and agomelatine) were found to improve sleep quality and efficiency without the adverse effects (e.g., cognitive impairment, dependence, hangover) associated with benzodiazepines and non-benzodiazepines. Agomelatine also improved depressive symptoms and sleep quality in patients with major depressive disorders.", "population_specificity": "Adult and elderly insomniacs, as well as patients with major depressive disorders.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:52.090889+00:00"}
{"study_id": 81562, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the potential therapeutic effects of melatonin, particularly its anticonvulsant properties, and its safety profile in various conditions, including epilepsy.", "results_summary": "Melatonin demonstrated anticonvulsant effects in experimental models and showed potential benefits in treating juvenile intractable epilepsy, though some studies reported proconvulsant effects. Adverse effects were rare and mild, but higher doses could cause cognitive and motor impairments.", "population_specificity": "Humans (including patients with epilepsy and neurologically disabled children) and experimental models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:52.497131+00:00"}
{"study_id": 81563, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 50, "study_goal": "The researchers aimed to investigate the potential role of melatonin in the pathogenesis of adolescent idiopathic scoliosis (AIS) and assess whether melatonin deficiency could be a causative factor.", "results_summary": "The study found mixed data on human melatonin levels and could not support melatonin deficiency as a causative factor in AIS. The role of melatonin in scoliosis remains unclear, and further research is needed to define its clinical efficacy and safety.", "population_specificity": "Adolescents with idiopathic scoliosis (AIS).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:52.685572+00:00"}
{"study_id": 81565, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether melatonin, as a physiological hormone, could prevent neurodegeneration and preserve motor function in both acute and chronic spinal cord injury (SCI) in rats.", "results_summary": "The study found that melatonin, along with estrogen, could successfully prevent neurodegeneration and preserve motor function in SCI models, suggesting its potential as a therapeutic agent for SCI.", "population_specificity": "Rats with acute and chronic spinal cord injury.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:54.667429+00:00"}
{"study_id": 81567, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review pharmacokinetic knowledge on melatonin and present results from recent studies on its use for sleep disorders in autism, including its impact on children with ASD.", "results_summary": "The study found that melatonin has been investigated for its usefulness in treating sleep disturbances in ASD, with altered melatonin levels detected in subgroups of ASD subjects. Hypotheses suggest dysfunctional melatonin synthesis may increase ASD risk and severity.", "population_specificity": "Children with autism spectrum disorder (ASD) evaluated in a Diagnostic Center for Autism Spectrum Disorder in Paris, France.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:55.380440+00:00"}
{"study_id": 81566, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether melatonin or L-tryptophan, when combined with omeprazole, accelerates the healing of chronic gastroduodenal ulcers in humans.", "results_summary": "Melatonin and L-tryptophan significantly accelerated ulcer healing compared to placebo when combined with omeprazole, with all ulcers healed by day 21 in the melatonin and tryptophan groups. Plasma melatonin and leptin levels increased significantly in these groups, suggesting a potential mechanism for the observed effects.", "population_specificity": "42 idiopathic patients with chronic gastroduodenal ulcers (14 per treatment group).", "effective_dosage": "Not specified (melatonin dosage not mentioned).", "study_duration": "21 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:55.883183+00:00"}
{"study_id": 81568, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine whether long-term melatonin use affects pubertal development, sleep quality, and mental health in children compared to the general Dutch population.", "results_summary": "The study found no statistically significant differences in sleep quality, puberty development, or mental health scores between melatonin-treated children and the general Dutch population. Long-term melatonin use (mean 3.1 years) was well-tolerated without substantial developmental deviations.", "population_specificity": "Dutch children previously enrolled in a melatonin dose-finding trial.", "effective_dosage": "Mean dose 2.69 mg (range 0.3\u201310 mg).", "study_duration": "Mean 3.1 years (range 1.0\u20134.6 years).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:59.736846+00:00"}
{"study_id": 81571, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the efficacy and safety of pharmacologic interventions, including Melatonin, for sleep disturbances in children with developmental disabilities.", "results_summary": "Melatonin was identified as the most widely assessed and safest choice for improving sleep in children with developmental disabilities, though more well-controlled studies are needed to confirm its efficacy and safety.", "population_specificity": "Children with developmental disabilities experiencing sleep disturbances.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:39:59.799874+00:00"}
{"study_id": 81570, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine the effects of medical filters, particularly in the green-yellow spectrum, on macular degeneration (AMD) and their influence on melatonin and serotonin levels.", "results_summary": "The study found that medical filters in the green-yellow range (565-570 nm) slowed AMD progression and improved depressive mood in patients. The filters also positively affected melatonin and serotonin balance, enhancing psychophysical stability.", "population_specificity": "Patients with threatened sight, specifically those with macular degeneration (AMD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:00.686553+00:00"}
{"study_id": 81569, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the effectiveness of oral melatonin, dexmedetomidine, and midazolam in reducing emergence agitation in children under sevoflurane anesthesia.", "results_summary": "Melatonin was as effective as dexmedetomidine and midazolam in reducing emergence agitation, with significantly lower agitation scores compared to placebo. No significant differences in agitation were found among the three active treatment groups.", "population_specificity": "100 children aged 3-9 years (ASA physical status I-II) undergoing general anesthesia for esophageal dilatation.", "effective_dosage": "0.1 mg/kg melatonin, given orally once 40-45 minutes before anesthesia induction.", "study_duration": "Single dose administered preoperatively.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:00.880212+00:00"}
{"study_id": 81572, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the effects of a 3-week progesterone administration on sleep architecture and hormonal profiles in postmenopausal women.", "results_summary": "Progesterone reduced sleep disturbances caused by blood sampling, increased slow-wave sleep duration and activity, and altered nocturnal GH and TSH levels, but had no effect on undisturbed sleep.", "population_specificity": "Eight healthy postmenopausal women aged 48-74 without sleep complaints or vasomotor symptoms.", "effective_dosage": "300 mg daily at 2300 h.", "study_duration": "3 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:01.212269+00:00"}
{"study_id": 81573, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the functions of Melatonin, focusing on its role in tumor processes, particularly in oral cavity tumors, and the involvement of MT receptors.", "results_summary": "The study highlights Melatonin's potential in the prognosis and treatment of tumors, including oral cavity epidermoid carcinoma, and suggests its protective role against tissue damage via receptor action.", "population_specificity": "Not specified (literature review, not a clinical study)", "effective_dosage": "Not available", "study_duration": "Not applicable (literature review)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:02.742419+00:00"}
{"study_id": 81575, "supplement_id": 1328, "safety_score": "70", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to review the clinical efficacy and safety of agomelatine, a melatonergic antidepressant, for treating depression and other potential indications.", "results_summary": "Agomelatine demonstrated antidepressant properties, improved sleep architecture early in treatment, and had fewer sexual side effects compared to SSRIs. It was well-tolerated but contraindicated in patients with impaired liver function.", "population_specificity": "Adults with depression, with potential indications for seasonal affective disorder and anxiety disorders.", "effective_dosage": "Not specified", "study_duration": "Short-term studies (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:03.424418+00:00"}
{"study_id": 81574, "supplement_id": 1328, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "To evaluate the safety and efficacy of ramelteon, a melatonin receptor agonist, in Japanese patients with chronic insomnia over 24 weeks.", "results_summary": "Ramelteon was well tolerated with minimal adverse events (11.6%), no significant residual effects, rebound insomnia, withdrawal symptoms, or dependence. Subjective sleep latency decreased and total sleep time increased significantly, plateauing by week 20 and sustaining thereafter.", "population_specificity": "Adult Japanese patients with chronic insomnia.", "effective_dosage": "4 or 8 mg, titrated up to 16 mg if necessary.", "study_duration": "24 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:05.198930+00:00"}
{"study_id": 81577, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to investigate abnormalities in neurotransmitters and neuromodulators, including melatonin, in patients with Rett syndrome (RTT).", "results_summary": "The abstract mentions melatonin as one of the factors investigated in RTT patients but does not provide specific findings regarding its effects.", "population_specificity": "Patients with Rett syndrome (RTT).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:06.403650+00:00"}
{"study_id": 81576, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize the mechanisms of action of melatonin in relation to mitochondrial pathologies, focusing on its antioxidant and anti-inflammatory effects.", "results_summary": "The study highlights melatonin's beneficial effects against oxidative/nitrosative stress, including mitochondrial dysfunction, due to its powerful antioxidant and anti-inflammatory properties. It suggests melatonin may help mitigate damage from reactive oxygen and nitrogen species in mitochondria.", "population_specificity": "Not specified (general discussion of mitochondrial pathologies)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:07.227380+00:00"}
{"study_id": 81579, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "To evaluate the effectiveness of ramelteon, a melatonin receptor agonist, for treating insomnia in older adults starting APAP therapy for sleep apnea.", "results_summary": "Ramelteon significantly improved objective sleep onset latency (28.5 min difference vs. placebo) but had no effect on subjective sleep latency or other sleep metrics. Adverse events were few and unrelated to treatment.", "population_specificity": "Older adults (\u226560 years) with obstructive sleep apnea (AHI \u22655 events/h) and insomnia complaints.", "effective_dosage": "8 mg ramelteon", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:08.750897+00:00"}
{"study_id": 81580, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review melatonin's hepatoprotective potential in various models of oxidative stress and evaluate its influence on hepatic antioxidant enzymes and related pathways.", "results_summary": "The study found that melatonin exhibits strong antioxidant properties and may reduce liver damage in conditions like sepsis, hemorrhagic shock, ischemia/reperfusion, and toxic liver injury. It also influences hepatic antioxidant enzymes, nitric oxide signaling, and cytokine expression.", "population_specificity": "Various in vivo models of oxidative stress (not human-specific).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:08.787711+00:00"}
{"study_id": 81578, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "To determine whether nightly administration of melatonin, magnesium, and zinc improves primary insomnia in long-term care facility residents.", "results_summary": "The food supplement significantly improved sleep quality (PSQI scores), total sleep time, and quality of life (SF-36 physical score) compared to placebo, with statistically significant improvements across multiple sleep-related metrics.", "population_specificity": "Long-term care facility residents with primary insomnia (average age 78.3 \u00b1 3.9).", "effective_dosage": "5 mg melatonin, 225 mg magnesium, and 11.25 mg zinc, mixed with 100 g of pear pulp, taken nightly.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:08.943467+00:00"}
{"study_id": 81581, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of different doses of melatonin, alone or combined with fluoxetine, for managing fibromyalgia syndrome (FMS).", "results_summary": "Melatonin (3 mg or 5 mg/day) combined with fluoxetine significantly reduced Fibromyalgia Impact Questionnaire (FIQ) scores compared to pretreatment values. Melatonin alone or with fluoxetine was effective in treating FMS.", "population_specificity": "101 patients (95 women, 6 men) meeting ACR criteria for FMS.", "effective_dosage": "3 mg or 5 mg melatonin daily, alone or with 20 mg fluoxetine.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:10.983426+00:00"}
{"study_id": 81582, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess melatonin's efficacy in improving metabolic and cardiovascular parameters in patients with metabolic syndrome (MS) who did not respond to lifestyle modifications.", "results_summary": "Melatonin significantly improved antioxidative defense (increased CAT activity, decreased TBARS), lipid profile (reduced LDL-C), and lowered blood pressure (SBP and DBP) in MS patients after 2 months of treatment.", "population_specificity": "30 patients with metabolic syndrome unresponsive to 3-month lifestyle modifications and 33 healthy volunteers.", "effective_dosage": "5 mg/day, taken 2 hours before bedtime.", "study_duration": "2 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:11.549146+00:00"}
{"study_id": 81583, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to review clinical and non-clinical data on melatonin's effects on the GI tract and its potential role in treating IBS.", "results_summary": "The study found that melatonin significantly improved IBS symptoms, including reduced abdominal pain and better overall symptom scores, and demonstrated anxiolytic, anti-inflammatory, antioxidant, and motility-regulating effects in the GI tract.", "population_specificity": "IBS patients and general GI disorder cases (based on reviewed studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:12.387589+00:00"}
{"study_id": 81584, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to determine whether circadian rhythm disturbances after surgery could be correlated with postoperative recovery and if melatonin administration could improve recovery.", "results_summary": "The study found circadian rhythm disturbances in melatonin secretion and other endogenous rhythms post-surgery. Melatonin substitution showed limited efficacy, improving recovery only in patients with lower pain levels after laparoscopic cholecystectomy.", "population_specificity": "Patients undergoing minor and major surgery.", "effective_dosage": "Not specified", "study_duration": "Three nights after surgery", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:14.442741+00:00"}
{"study_id": 81585, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy and safety of exogenous melatonin in advancing sleep-wake rhythm in patients with delayed sleep phase disorder through a meta-analysis of randomized controlled trials.", "results_summary": "Melatonin treatment advanced endogenous melatonin onset by 1.18 hours and sleep onset by 0.67 hours, while reducing sleep-onset latency by 23.27 minutes. Wake-up time and total sleep time did not change significantly.", "population_specificity": "Adults and children with delayed sleep phase disorder.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:15.230458+00:00"}
{"study_id": 81586, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of melatonin in the context of seizures associated with multiple sclerosis (MS) and its interaction with other biochemical pathways.", "results_summary": "The study suggests that increased kynurenine pathway activity reduces serotonin and melatonin availability, potentially contributing to seizures in MS. Antiepileptic drugs were noted to interact with melatonin and vitamin D3, influencing MS symptomatology.", "population_specificity": "Individuals with multiple sclerosis (MS) experiencing seizures.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Antiepileptic drugs and vitamin D3", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:16.493723+00:00"}
{"study_id": 81587, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether intraplatelet melatonin levels correlate with angiographic no-reflow after primary percutaneous coronary intervention (PPCI) in patients with ST-segment elevation myocardial infarction (STEMI).", "results_summary": "The study found that patients with angiographic no-reflow had significantly lower intraplatelet melatonin levels compared to those without no-reflow. Intraplatelet melatonin levels were the only significant predictor of angiographic no-reflow after adjusting for confounders.", "population_specificity": "180 consecutive patients with a first STEMI who underwent PPCI within 6 hours from symptom onset.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:17.695899+00:00"}
{"study_id": 81588, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the short- and long-term efficacy and safety of prolonged-release melatonin (PRM) in treating insomnia, particularly focusing on age-specific responses and maintenance of effects.", "results_summary": "PRM significantly improved sleep latency and other sleep variables in patients aged 55-80, with benefits maintained over 6 months without tolerance. Safety was excellent, with no withdrawal symptoms or rebound insomnia, and adverse events were mostly mild and comparable to placebo.", "population_specificity": "Males and females aged 18-80 with primary insomnia (focus on 55-80 subgroup).", "effective_dosage": "2 mg once daily, 2 hours before bedtime.", "study_duration": "3 weeks of double-blind treatment, followed by 26 weeks of extended treatment for some participants.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:17.758689+00:00"}
{"study_id": 81589, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to determine the effectiveness of melatonin in treating circadian rhythm disturbances, such as sundowning and agitated behavior, in patients with dementia and its potential effects in delirium.", "results_summary": "Melatonin treatment improved sundowning/agitated behavior in dementia patients, with two RCTs and all five case series showing positive results. Effects on sleep quality and daytime functioning were inconclusive.", "population_specificity": "Patients with dementia and potential implications for patients with delirium.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:18.758431+00:00"}
{"study_id": 81590, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of melatonin on biochemical parameters, including proinflammatory cytokine levels, in patients with NASH.", "results_summary": "Melatonin treatment significantly reduced GGTP, triglycerides, and proinflammatory cytokine levels in NASH patients, with elevated plasma melatonin levels observed. No significant changes were noted in the placebo group.", "population_specificity": "45 patients with histopathologically confirmed NASH, divided into three groups.", "effective_dosage": "5 mg melatonin twice daily.", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:19.019281+00:00"}
{"study_id": 81591, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the role of melatonergic mechanisms in glaucoma, circadian rhythm regulation, and depression, and explore melatonin's potential as a treatment strategy.", "results_summary": "The study suggests that melatonergic drugs may offer a promising treatment approach for glaucoma by addressing circadian dysregulation, sleep disorders, and depression, while also providing retinal neuroprotection. Glaucoma may serve as a model for studying interactions between melatonergic, circadian, and mood systems.", "population_specificity": "Glaucoma patients, particularly those with associated circadian rhythm dysregulation, sleep disorders, and depression.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:20.773479+00:00"}
{"study_id": 81592, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of melatonin on sleep-wake patterns, plasma melatonin levels, and urinary excretion of its metabolite in children with severe epileptic disorders, as well as its impact on seizure control.", "results_summary": "Melatonin significantly improved sleep efficiency, reduced night-time awakenings, restored periodic plasma melatonin levels, and decreased the number of seizures in pediatric patients with severe epilepsy.", "population_specificity": "Pediatric patients with severe epileptic disorders (n=10).", "effective_dosage": "3 mg nightly.", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:22.313598+00:00"}
{"study_id": 81593, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate melatonin's antioxidant properties, its role in infant development, and its potential therapeutic uses in sleep disorders and analgesia.", "results_summary": "Melatonin demonstrated strong antioxidant effects, reducing oxidative stress in newborns with sepsis or hypoxic distress, and showed potential as a sleep-promoting and analgesic agent in both adults and children.", "population_specificity": "Human newborns, infants, children, and adults.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:22.407361+00:00"}
{"study_id": 81594, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to determine whether prolonged-release melatonin (2 mg) taken before bedtime is effective as a migraine prophylaxis compared to placebo.", "results_summary": "The study found no significant difference in migraine attack frequency between melatonin and placebo (p = 0.497), and sleep quality did not improve. Absolute risk reduction was minimal (3%), indicating melatonin was not effective for migraine prevention.", "population_specificity": "Men and women aged 18-65 with migraine (2-7 attacks/month) but otherwise healthy.", "effective_dosage": "2 mg extended-release melatonin (Circadin\u00ae) 1 hour before bedtime.", "study_duration": "8 weeks per treatment phase (with a 6-week washout).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:26.202881+00:00"}
{"study_id": 81597, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to explore the role of melatonin in addressing sleep disturbances caused by asynchronization of biological rhythms in children.", "results_summary": "The study suggests that disturbances in melatonin secretion due to nighttime light exposure and lack of morning light may contribute to sleep issues like daytime sleepiness and insomnia. Early-phase asynchronization may be reversible with improved sleep hygiene, but chronic cases require further intervention.", "population_specificity": "Children in Japan reporting daytime sleepiness and/or insomnia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:27.017579+00:00"}
{"study_id": 81598, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the safety and efficacy of the Di Bella Method (DBM), which includes Melatonin, in improving quality of life and survival rates in cancer patients compared to conventional treatments.", "results_summary": "The study reported an improvement in quality of life and increased mean survival rates in 553 cancer patients treated with DBM, without significant toxic effects compared to chemotherapy or monoclonal antibodies. The results suggest Melatonin, as part of DBM, may have antitumoral efficacy with low toxicity.", "population_specificity": "553 cancer patients with various diseases and stages.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:27.840952+00:00"}
{"study_id": 81595, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the regulatory effects of melatonin on matrix metalloproteinases (MMPs) and its potential therapeutic significance in diseases involving oxidative stress and tissue remodeling.", "results_summary": "The study suggests that melatonin may mitigate oxidative stress-related tissue injury and regulate MMP activities, which are involved in cellular processes like proliferation, angiogenesis, and metastasis. The review highlights melatonin's potential therapeutic role via MMP regulation.", "population_specificity": "Not specified (review article)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:28.317835+00:00"}
{"study_id": 81596, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate melatonin's protective effects on smooth muscle dysfunction, focusing on its antioxidative properties and modulation of contractile responses in various pathological conditions.", "results_summary": "Melatonin reduced vascular tone in hypertensive or aged animals, improved gastrointestinal and gallbladder contractility, restored detrusor muscle function in old animals, and reversed bladder damage post-ischemia/reperfusion, primarily through antioxidative mechanisms and modulation of neuromuscular function.", "population_specificity": "Aged animals, hypertensive animals, and constipation-predominant IBS patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:29.210019+00:00"}
{"study_id": 81600, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the antidepressant and anxiolytic efficacy and safety of agomelatine, a melatonergic agonist, in treating Major Depressive Disorder (MDD).", "results_summary": "Agomelatine demonstrated significant antidepressant efficacy in MDD patients, including severe cases, with early onset of action and minimal adverse effects. It also showed potential anxiolytic benefits for both MDD-associated anxiety and generalized anxiety disorder.", "population_specificity": "Patients with Major Depressive Disorder (MDD), including those with severe manifestations and residual subthreshold symptoms.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:30.971744+00:00"}
{"study_id": 81601, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate whether low-dose exogenous melatonin could reduce the occurrence of delirium in elderly hospitalized patients.", "results_summary": "Melatonin was associated with a significantly lower risk of delirium (12.0% vs. 31.0%, p = 0.014) compared to placebo, with an adjusted odds ratio of 0.19 (95% CI: 0.06-0.62). The effect remained consistent even after excluding patients with prevalent delirium.", "population_specificity": "Elderly individuals aged 65 years or older admitted to a medical unit in a tertiary care hospital.", "effective_dosage": "0.5 mg nightly", "study_duration": "14 days or until discharge", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:31.040255+00:00"}
{"study_id": 81599, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were examining the role of various neurochemicals, including melatonin, in the pathophysiology of bipolar disorder and treatment-emergent mania.", "results_summary": "The abstract does not provide specific findings regarding melatonin's effects, focusing instead on other neurochemicals and medications like paroxetine, fluoxetine, and venlafaxine.", "population_specificity": "Patients with bipolar disorder (types I and II).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:31.138600+00:00"}
{"study_id": 81602, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to explore whether interventions like melatonin could improve sleep disturbances in children with ADHD and potentially attenuate associated symptoms.", "results_summary": "The abstract suggests that melatonin, among other interventions, could potentially help mitigate sleep problems in children with ADHD, which may in turn reduce symptoms like irritability. However, the study does not provide specific data on melatonin's efficacy compared to other interventions.", "population_specificity": "Children and adolescents with ADHD experiencing sleep disturbances.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:33.780251+00:00"}
{"study_id": 81603, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 50, "study_goal": "The researchers aimed to explore the potential of melatonin as a treatment option for hypnic headache, alongside other medications like lithium and indomethacin.", "results_summary": "Melatonin was promoted as a potent medical treatment for hypnic headache, though efficacy was primarily supported by single case reports rather than systematic studies. The abstract does not provide specific data on melatonin's effectiveness compared to other treatments.", "population_specificity": "Patients with hypnic headache, typically beyond 50 years of age.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:34.621662+00:00"}
{"study_id": 81604, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effectiveness of melatonin in managing behavioral symptoms of dementia in older adults in long-term care settings.", "results_summary": "The study found negative results regarding melatonin's efficacy in managing behavioral symptoms of dementia, indicating it did not demonstrate significant benefits in this context.", "population_specificity": "Older adults in long-term care homes with behavioral symptoms of dementia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:35.790935+00:00"}
{"study_id": 81605, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore whether stimulation of brain function, including the use of melatonin, could slow brain aging and reduce the risk of neurodegenerative diseases like Alzheimer's.", "results_summary": "The study found that giving melatonin and/or bright light to Alzheimer's patients improved rest-activity rhythms and ameliorated cognitive and noncognitive symptoms, suggesting affected neurons can still be reactivated.", "population_specificity": "Alzheimer's disease patients", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:36.315501+00:00"}
{"study_id": 81608, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of melatonin in modulating pain and its potential therapeutic implications for primary headaches, particularly migraine.", "results_summary": "The study suggests melatonin is a significant element in migraine and other headache disorders, with potential therapeutic applications, linking its effects to circadian rhythms and hormonal fluctuations.", "population_specificity": "Individuals with primary headaches, particularly migraine.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:38.138204+00:00"}
{"study_id": 81607, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of melatonin and melatonergic agonists in treating jet lag symptoms and associated circadian rhythm disruptions.", "results_summary": "The study found that strategically timed melatonin administration and environmental schedule adjustments effectively counteract circadian dysregulation in jet lag. Melatonergic agonists like ramelteon and tasimelteon showed promise in improving sleep disturbances and daytime alertness, while agomelatine was effective for depressive symptoms linked to jet lag.", "population_specificity": "Air travel passengers susceptible to jet lag and circadian rhythm disruptions.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:38.736748+00:00"}
{"study_id": 81609, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to explore the potential roles of vitamin D and the pineal-melatonin system in mental disorders, particularly seasonal affective disorders, schizophrenia, and autism.", "results_summary": "The abstract suggests a possible link between vitamin D deficiency and mental disorders, including schizophrenia and autism, but does not provide conclusive evidence on melatonin's role. Psychiatric improvement was noted in two cases after treating vitamin D deficiency.", "population_specificity": "Patients with depressive disorders, schizophrenia, autism, and seasonal affective disorders.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:39.230580+00:00"}
{"study_id": 81606, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine if melatonin alters the vestibulosympathetic reflex (VSR) and vestibulocollic reflex (VCR) in humans.", "results_summary": "Melatonin significantly attenuated MSNA responses during head-down rotation (HDR) compared to placebo, indicating an effect on the VSR, but did not alter the timing or amplitude of vestibular evoked myogenic potentials (VEMP), suggesting no effect on the VCR.", "population_specificity": "12 healthy subjects (28 \u00b1 1 yr; 6 men, 6 women) for study 1; 10 healthy subjects (26 \u00b1 1 yr; 4 men, 6 women) for study 2.", "effective_dosage": "3 mg melatonin (single dose).", "study_duration": "Acute (45 minutes post-ingestion for study 1; timing not specified for study 2).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:39.912932+00:00"}
{"study_id": 81611, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to review the relationship between pineal cysts and headaches, as well as melatonin's role in headache therapy and other disorders.", "results_summary": "The abstract indicates that the role of pineal cysts in headache pathophysiology and melatonin's potential in headache therapy remains unclear due to a lack of large prospective studies. A clinical case is included to illustrate the subject.", "population_specificity": "Not specified (general discussion, no specific population studied).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:42.419646+00:00"}
{"study_id": 81613, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to explore the therapeutic potential of melatonin, focusing on its physiological actions, pharmacological effects, and clinical applications.", "results_summary": "Melatonin demonstrates therapeutic benefits for circadian rhythm disorders, sleep disturbances, and neuroendocrine regulation, with additional potential in neurodegenerative and neoplastic diseases, though further confirmatory studies are needed.", "population_specificity": "General population, including individuals with circadian rhythm disorders, sleep disturbances, blind people, and shift workers.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:44.540903+00:00"}
{"study_id": 81612, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 75, "quality_score": 90, "study_goal": "The researchers aimed to determine whether age or low melatonin levels better predict response to prolonged-release melatonin (PRM), assess its long-term efficacy, and evaluate its safety in treating primary insomnia.", "results_summary": "PRM significantly reduced sleep latency in elderly patients regardless of melatonin levels, with effects maintained over 6 months without tolerance. Low melatonin production was not a useful predictor of response. Most adverse events were mild, with no significant safety differences between PRM and placebo.", "population_specificity": "Adult outpatients (aged 18-80 years) with primary insomnia, including a focus on elderly patients (55+ years).", "effective_dosage": "Not specified in the abstract.", "study_duration": "3 weeks initial treatment, followed by 26 weeks for continued evaluation.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:45.566984+00:00"}
{"study_id": 81615, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate whether agomelatine offers significant advantages for patients with major depressive episodes by acting as a melatonin receptor agonist and serotonin receptor antagonist.", "results_summary": "The abstract suggests agomelatine may represent a therapeutic advance in depression management by restoring circadian rhythms, but it does not provide specific efficacy data or comparative outcomes.", "population_specificity": "Patients with major depressive episodes.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:45.835614+00:00"}
{"study_id": 81616, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness of melatonin as a preventive therapy for cluster headache.", "results_summary": "The study found that melatonin 10 mg received Level C advice for the prevention of cluster headaches, indicating limited or weak evidence supporting its efficacy.", "population_specificity": "Patients with cluster headache.", "effective_dosage": "10 mg.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:45.922656+00:00"}
{"study_id": 81617, "supplement_id": 1328, "safety_score": "70", "efficacy_score": 20, "quality_score": 80, "study_goal": "The researchers aimed to determine whether perioperative melatonin treatment could reduce oxidative and inflammatory stress markers in patients undergoing major vascular surgery.", "results_summary": "Melatonin treatment did not significantly reduce oxidative or inflammatory stress parameters compared to placebo. The melatonin group reported significantly more side effects than the placebo group.", "population_specificity": "Patients undergoing major vascular surgery.", "effective_dosage": "Intra-operative intravenous infusion of 50 mg melatonin, followed by 10 mg melatonin orally for the first 3 nights after surgery.", "study_duration": "Intra-operative infusion plus 3 days post-surgery.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:48.150083+00:00"}
{"study_id": 81618, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to explore the role of stress neuropeptides, including melatonin, in the pathophysiological sequelae of critical illness.", "results_summary": "The study found that melatonin, among other neuropeptides, is involved in stress responses and may be altered in critical illness, potentially mediating processes like immunity and oxidative stress. However, data were insufficient to draw firm conclusions.", "population_specificity": "Critically ill individuals", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:51.362252+00:00"}
{"study_id": 81619, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential benefits of combining melatonin with exercise for improving functional recovery and reducing oxidative stress-induced secondary damage after spinal cord injury (SCI).", "results_summary": "The study suggests that melatonin, due to its antioxidant properties, can protect tissue from oxidative stress-induced damage post-SCI. Combining melatonin with exercise may enhance functional recovery and mitigate secondary tissue damage more effectively than either treatment alone.", "population_specificity": "Individuals with spinal cord injury (SCI).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:52.651862+00:00"}
{"study_id": 81621, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 40, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the efficacy of melatonin as a preventive treatment for hypnic headache, either alone or in combination with other medications.", "results_summary": "Melatonin did not show robust evidence as a single preventive agent for hypnic headache, but its combination with lithium or indomethacin appeared to enhance therapeutic efficacy.", "population_specificity": "Patients with hypnic headache, primarily aged 50 years and older.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:53.757854+00:00"}
{"study_id": 81610, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the use of melatonin metabolites as surrogate measures for assessing sleep impairment in hospitalized patients, particularly those undergoing surgery or in intensive care.", "results_summary": "The study found that melatonin metabolites are used as surrogate measures for sleep assessment, showing marked sleep impairment in hospitalized patients, especially those with sepsis or on mechanical ventilation, who may lose normal circadian rhythms. Postoperative patients also exhibited significant sleep disruption, particularly REM sleep, linked to high-dose opioid use.", "population_specificity": "Hospitalized patients, including surgical patients, those in the medical intensive care unit with sepsis, and patients requiring mechanical ventilation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:53.782522+00:00"}
{"study_id": 81620, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness and safety of melatonin in treating sleep disorders, particularly insomnia, in children and adolescents with autistic spectrum disorders (ASD).", "results_summary": "The study found that melatonin is effective and safe for long-term use in improving sleep onset and maintenance in children with ASD, with behavioral interventions also showing effectiveness but sometimes requiring pharmacological supplementation.", "population_specificity": "Children and adolescents with autistic spectrum disorders (ASD) experiencing sleep problems, particularly insomnia.", "effective_dosage": "Not specified", "study_duration": "Long-term (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:54.052971+00:00"}
{"study_id": 81622, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the potential of agomelatine, a melatonergic agonist and 5-HT2C antagonist, as a novel non-monoaminergic treatment for major depression.", "results_summary": "Agomelatine demonstrated efficacy in treating major depression, leading to its approval in Europe in 2009 as the first antidepressant with a non-monoaminergic mechanism. The study highlighted its role in synchronizing circadian rhythms, which are often disrupted in depression.", "population_specificity": "Patients with major depression.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:55.018404+00:00"}
{"study_id": 81614, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential neuroprotective effects of melatonin in reducing perinatal hypoxic-ischemic brain injury, particularly focusing on its anti-inflammatory properties.", "results_summary": "The study suggests melatonin, alongside other compounds, may be effective in the early post-hypoxic-ischemic phase by targeting anti-inflammatory pathways to mitigate brain injury. However, the abstract does not provide specific data on melatonin's efficacy compared to other interventions.", "population_specificity": "Neonates with perinatal hypoxic-ischemic brain injury.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:56.370448+00:00"}
{"study_id": 81623, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of a dietary supplement (including Humulus lupulus extract) on sleep quality and melatonin metabolism in individuals with moderate to severe sleep disorders.", "results_summary": "The study found no significant differences between the active and placebo groups in perceived sleep quality, melatonin metabolism (urinary melatonin and aMT6S levels), or sleep efficiency measured by actigraphy. Both groups showed similar improvements in sleep quality.", "population_specificity": "Adult patients aged 25-65 with chronic primary insomnia.", "effective_dosage": "Not specified for melatonin (ancillary study).", "study_duration": "1 month.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:57.075795+00:00"}
{"study_id": 81624, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review evidence for time-of-day effects on anesthetic drugs, including potential circadian influences on pharmacokinetics and pharmacodynamics in adults and children.", "results_summary": "The abstract notes that robust circadian rhythms in hormone production (e.g., melatonin) emerge around 3 months of age, but it remains unclear when daily rhythms in drug PK/PD appear. No specific findings on melatonin's effects are detailed.", "population_specificity": "Adults and children (pediatric focus implied).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:40:59.458578+00:00"}
{"study_id": 81626, "supplement_id": 1328, "safety_score": "90", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore melatonin's potential role in treating obesity by enhancing brown adipose tissue (BAT) activity and recruitment.", "results_summary": "Melatonin was found to increase the recruitment and metabolic activity of brown adipocytes, suggesting a potential novel approach for obesity treatment. The study also highlighted that excessive nighttime light exposure may reduce melatonin production, potentially contributing to obesity.", "population_specificity": "Mammals (with speculation on human applicability)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:41:01.221238+00:00"}
{"study_id": 81627, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the impact of chronic sleep loss, including its effects on melatonin production and circadian physiology, and its potential long-term consequences on brain development and neuronal function.", "results_summary": "The study found that chronic sleep loss disrupts melatonin production, leading to disturbances in circadian physiology, neuronal function, and cognitive decline, with potential long-term neuronal damage and impaired brain development.", "population_specificity": "Children, particularly those with neurodevelopmental disabilities.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:41:01.969508+00:00"}
{"study_id": 81625, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to confirm whether exogenous melatonin improves REM sleep behaviour disorder (RBD) by reducing muscle atonia loss during REM sleep and improving clinical symptoms.", "results_summary": "Melatonin significantly reduced the number of REM sleep epochs without muscle atonia (39% to 27%) and improved clinical global impression scores (6.1 to 4.6). Some benefits persisted even after switching to placebo, suggesting a potential carryover effect.", "population_specificity": "Eight males (mean age 54 years) with polysomnographically confirmed RBD.", "effective_dosage": "3 mg daily, administered between 22:00 h and 23:00 h.", "study_duration": "4 weeks per treatment phase (placebo and melatonin) in a cross-over design.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:41:02.776557+00:00"}
{"study_id": 81629, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the biological role of melatonin and its circadian rhythm in cardiovascular disease, focusing on its antioxidant, anti-inflammatory, chronobiotic, and epigenetic regulatory functions.", "results_summary": "The study highlights melatonin's role in synchronizing molecular circadian clocks and its influence on cardiovascular functions, including blood pressure regulation. It also emphasizes melatonin's potential benefits in cardiovascular disease through its antioxidant and anti-inflammatory properties.", "population_specificity": "Not specified (review article)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:41:02.863499+00:00"}
{"study_id": 81630, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to explore the potential health benefits of melatonin found in Mediterranean plant foods and its role in reducing the risk of chronic-degenerative disorders.", "results_summary": "The study suggests that melatonin in edible plants may improve human health due to its biological activities and good bioavailability, potentially reducing risks of cancer, cardiovascular, and neurodegenerative diseases, though data are preliminary.", "population_specificity": "Mediterranean populations", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:41:03.648378+00:00"}
{"study_id": 81628, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether ramelteon (a melatonin agonist) improves daytime sleep by reducing core body temperature, increasing the distal-proximal skin gradient, and enhancing sleep metrics like sleep onset latency and total sleep time.", "results_summary": "Ramelteon significantly reduced core temperature, increased the distal-proximal skin gradient, decreased wakefulness after sleep onset, and increased total sleep time and stages 1 and 2 sleep during daytime sleep. The changes in skin temperature gradient were negatively correlated with sleep onset latency.", "population_specificity": "14 healthy adults (5 females), aged 23.2 \u00b1 4.2 years.", "effective_dosage": "8 mg ramelteon administered once, 2 hours before a 4-hour daytime sleep opportunity.", "study_duration": "Single administration with a 4-hour sleep observation period.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:41:04.143064+00:00"}
{"study_id": 81631, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the development and potential therapeutic applications of melatonin receptor agonists for treating sleep disturbances, depression, and other CNS-related pathologies.", "results_summary": "The study found that melatonin receptor agonists show promise for treating CNS-related conditions, with improved pharmacokinetic and pharmacodynamic properties compared to existing treatments. Preclinical studies on animal models support their efficacy, but clinical evidence remains under review.", "population_specificity": "Not specified (review of patents and literature, including preclinical animal studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:41:05.206926+00:00"}
{"study_id": 81633, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 80, "study_goal": "The researchers aimed to assess the effect of acute sleep deprivation on urine output and renal water, sodium, and solute handling, including melatonin excretion.", "results_summary": "The study found that urinary melatonin excretion levels were comparable between sleep deprivation and baseline night, indicating no significant change due to sleep deprivation.", "population_specificity": "20 healthy young adults (10 male, 10 female).", "effective_dosage": "Not specified.", "study_duration": "Two 24-hour study periods (one with sleep deprivation).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:41:09.165208+00:00"}
{"study_id": 81632, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 50, "study_goal": "The researchers aimed to review the use of melatonin as a second-line therapy for REM sleep behaviour disorder (RBD).", "results_summary": "The abstract mentions melatonin as a second-line therapy for RBD, but evidence comes from uncontrolled case series, indicating limited robust data on its efficacy. No specific outcomes or statistical results are provided regarding melatonin's effects.", "population_specificity": "Older adults with REM sleep behaviour disorder (RBD), including those with neurodegenerative diseases like Parkinson's disease, dementia with Lewy bodies, and multiple systems atrophy.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:41:09.310118+00:00"}
{"study_id": 81634, "supplement_id": 1328, "safety_score": "90", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate melatonin's potential role in treating ocular diseases like glaucoma and uveitis by examining its antioxidant and antinitridergic properties.", "results_summary": "The study suggests melatonin effectively scavenges free radicals and reduces excessive nitric oxide in ocular tissues, indicating promise for treating glaucoma and uveitis. Melatonin's synthesis in the eye and receptor localization support its therapeutic potential without significant adverse effects.", "population_specificity": "Ocular disease patients (glaucoma, uveitis)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:41:10.145471+00:00"}
{"study_id": 81637, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore melatonin's physiological roles and therapeutic potential, particularly in sleep regulation, immunomodulation, antioxidant effects, and treatment of inflammation and septic shock.", "results_summary": "Melatonin demonstrated significant anti-inflammatory, antioxidant, and mitochondrial-protective effects in animal models and septic patients, with potential benefits in reducing cellular damage and multiorgan failure. It also showed efficacy in combating bacterial and viral infections.", "population_specificity": "Animal models and patients with septic disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:41:10.991404+00:00"}
{"study_id": 81638, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore melatonin's role in preventing mitochondrial dysfunction and disease, focusing on its antioxidant properties and protective effects on cardiolipin.", "results_summary": "Melatonin was found to protect mitochondria from oxidative damage by preventing cardiolipin oxidation, suggesting its potential therapeutic benefits in mitochondrial dysfunction and degenerative processes.", "population_specificity": "Not specified (general cellular/mitochondrial focus)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:41:11.159099+00:00"}
{"study_id": 81635, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate melatonin's potential as a cardioprotective agent, particularly in treating cardiovascular conditions such as essential hypertension, ischemia/reperfusion injury, and cardiac hypertrophy.", "results_summary": "Melatonin was found effective in reducing the severity of essential hypertension, limiting abnormal cardiac physiology and tissue loss from ischemia/reperfusion injury, and potentially reducing cardiac hypertrophy. It also showed promise in mitigating drug-induced cardiotoxicity due to its antioxidative properties.", "population_specificity": "Human and rodent studies.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:41:11.278009+00:00"}
{"study_id": 81639, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the clinical efficacy and safety of melatonin across various medical conditions and its use as an adjuvant therapy.", "results_summary": "Melatonin was found to be effective as an adjuvant therapy for conditions like macular degeneration, glaucoma, sleep disorders, and neurological diseases, with low toxicity across a wide dose range. Preliminary data for fibromyalgia, chronic fatigue syndrome, and neonatal care were inconclusive, while results for ulcerative colitis and rheumatoid arthritis were ambiguous or negative.", "population_specificity": "Patients with various medical conditions including ocular, cardiovascular, neurological, and sleep disorders, among others.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:41:13.381259+00:00"}
{"study_id": 81640, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to describe melatonin's beneficial antioxidant properties and its potential therapeutic applications in various pathological conditions.", "results_summary": "Melatonin demonstrated strong antioxidant effects by scavenging free radicals and regulating antioxidant enzymes, showing efficacy in acute (e.g., sepsis, neonatal asphyxia) and chronic conditions (e.g., neurodegenerative diseases, cancer, aging). Its amphiphilic nature allows it to reduce oxidative damage in both lipid and aqueous cellular environments.", "population_specificity": "Broad, including conditions like cardiovascular disease, neurological disorders, metabolic diseases, and aging.", "effective_dosage": "Not specified (mentions \"supraphysiological dosages\" but no exact amounts).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:41:14.215042+00:00"}
{"study_id": 81641, "supplement_id": 1328, "safety_score": "90", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to evaluate melatonin's potential as a therapeutic agent for neurodegenerative diseases, focusing on its antioxidant and antiapoptotic properties.", "results_summary": "The abstract highlights melatonin's natural origin, antioxidant and antiapoptotic effects, and lack of toxicity in humans, though clinical trial data is lacking. It suggests melatonin may be a promising candidate for treating neurodegenerative disorders.", "population_specificity": "Not specified (general discussion on neurodegenerative diseases).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:41:17.552256+00:00"}
{"study_id": 81643, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 50, "study_goal": "The researchers aimed to evaluate whether chronic melatonin treatment could normalize cortisol rhythm and influence disease progression in advanced cancer patients with altered cortisol circadian rhythm.", "results_summary": "Melatonin normalized cortisol rhythm in 29% of patients and was associated with stable disease in 43% of cases, suggesting a potential link between cortisol rhythm normalization and disease stabilization.", "population_specificity": "14 untreatable metastatic cancer patients with altered cortisol rhythm.", "effective_dosage": "20 mg/day orally, in the evening.", "study_duration": "3 consecutive months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:41:17.917654+00:00"}
{"study_id": 81642, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to investigate melatonin's influence on the expression and function of nicotinic acetylcholine receptors (nAChRs) and its potential therapeutic role in Alzheimer's disease.", "results_summary": "Melatonin selectively increased the efficiency of alpha-bungarotoxin-sensitive nAChRs in various tissues and was found essential for their development and maintenance in aging models. The study suggests a potential therapeutic strategy combining melatonin replacement with cholinergic drugs for Alzheimer's disease.", "population_specificity": "Rat sympathetic nerve terminals, cerebellum, skeletal muscle, and chick retina (animal models).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:41:18.310500+00:00"}
{"study_id": 81645, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 60, "study_goal": "The researchers aimed to explore the potential role of melatonin in the development of hypothalamic obesity (HyOb).", "results_summary": "The abstract suggests that dysregulation of melatonin may contribute to HyOb, but no specific findings on its effects are detailed. The study reviews broader treatment strategies without focusing on melatonin's efficacy.", "population_specificity": "Patients with hypothalamic obesity due to various causes (e.g., tumors, genetic disorders, drug side effects).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:41:18.965081+00:00"}
{"study_id": 81644, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to assess melatonin levels in children with intractable epilepsy, its relation to sleep patterns and seizure characteristics, and the effects of melatonin therapy on these parameters.", "results_summary": "Melatonin therapy significantly improved multiple sleep-related issues (e.g., sleep latency, nocturnal arousals, sleep apnea) and reduced seizure severity in children with intractable epilepsy.", "population_specificity": "Children with intractable epilepsy (n=23) and children with controlled seizures (n=14).", "effective_dosage": "Not specified", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:41:19.178859+00:00"}
{"study_id": 81646, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to examine the metabolism of melatonin and other xenobiotics using advanced analytical techniques and genetically modified mice.", "results_summary": "The study expanded the metabolic maps of melatonin, revealing new insights into its metabolism, but did not specifically report on its safety or efficacy. The use of transgenic mice helped attribute metabolic pathways to specific enzymes.", "population_specificity": "Genetically modified mice (not specified for humans).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:41:19.781704+00:00"}
{"study_id": 81647, "supplement_id": 1328, "safety_score": "80", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the safety and effectiveness of melatonin in treating insomnia in children with autistic spectrum disorder (ASD) and explore its potential role in ASD etiology.", "results_summary": "Melatonin showed promising results in treating insomnia in children with ASD, with more data supporting its safety and effectiveness compared to other sedative/hypnotic drugs. A dual treatment approach combining melatonin and behavioral techniques was suggested, and low melatonin concentration was identified as a potential risk factor for ASD.", "population_specificity": "Children with autistic spectrum disorder (ASD) experiencing sleep problems, particularly insomnia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:41:21.761418+00:00"}
{"study_id": 81648, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to explore the potential mechanisms by which melatonin could alleviate tinnitus, focusing on its various physiological properties.", "results_summary": "The abstract suggests melatonin may relieve tinnitus through multiple mechanisms, including CNS modulation, improved hemodynamics, muscle tone reduction, antidepressant effects, and immune regulation in the inner ear. These properties collectively justify further investigation into melatonin as a tinnitus treatment.", "population_specificity": "Not specified (theoretical analysis based on melatonin's properties).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:41:22.246857+00:00"}
{"study_id": 84376, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the effectiveness of mindfulness-based programs in improving cancer-related stress.", "results_summary": "The study found that mindfulness-based programs were effective in addressing cancer-related stress, contributing to improved emotional well-being in patients. The literature reviewed supported the positive impact of mindfulness on managing negative emotions associated with cancer.", "population_specificity": "Patients with cancer experiencing negative emotions and stress.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:41:30.406483+00:00"}
{"study_id": 84377, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the relative impact of cognitive fusion and reappraisal on student mental health and functioning outcomes.", "results_summary": "Cognitive fusion predicted multiple mental health concerns (distress, depression, anxiety, hostility, academic distress, and role problems) longitudinally, while reappraisal only predicted student role problems. Cognitive fusion was identified as a stronger predictor of mental health issues than reappraisal.", "population_specificity": "College students (n = 339)", "effective_dosage": "Not available", "study_duration": "1 month follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:41:31.014492+00:00"}
{"study_id": 84378, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the connections between psychological well-being (including mindfulness-based programs) and cardiovascular health, and to propose clinical recommendations and a research agenda.", "results_summary": "Mindfulness-based programs and positive psychological interventions show promise for improving psychological well-being, which is linked to better cardiovascular health through biological, behavioral, and psychosocial pathways. Workplace interventions may serve as a model for broader community applications.", "population_specificity": "General population, with a focus on workplace settings for intervention applicability.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:41:31.141974+00:00"}
{"study_id": 84375, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to assess associations between subjective well-being, religiosity, anxiety, and other factors, including the potential role of mindfulness techniques in improving well-being and reducing anxiety among medical students.", "results_summary": "The study found that mindfulness techniques were suggested as a potential intervention to decrease anxiety and increase subjective well-being, though the abstract does not provide specific efficacy data for mindfulness alone. Lower anxiety and intrinsic religiosity were associated with higher well-being scores.", "population_specificity": "Brazilian medical students from a public university in northeastern Brazil (n=417).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:41:31.746714+00:00"}
{"study_id": 84379, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether mindfulness-based treatment produces changes in plasma catecholamines and elusive amines similar to pharmacological prophylaxis in patients with chronic migraine and medication overuse headache.", "results_summary": "Both pharmacological prophylaxis and mindfulness treatment groups showed significant improvements in headache frequency, medication intake, and catecholamine levels (noradrenaline, epinephrine, dopamine) after 12 months, with no significant changes in elusive amines. The results suggest mindfulness-based treatment may be as effective as pharmacological prophylaxis for these outcomes.", "population_specificity": "Adults aged 18-65 with chronic migraine (\u226510 years) and medication overuse (\u22655 years of triptans or NSAIDs).", "effective_dosage": "Six weekly sessions of mindfulness-based treatment.", "study_duration": "12 months (including follow-up).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:41:31.882149+00:00"}
